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Abstract 
Objectives: The present study examined the basal blood pressure (BP) and salt 
sensitivity of et:Idothelial nitric oxide synthase (eNOS) knockout (KO) mice and their 
control strain (C57) mice. 
Methods: Mice, age 12-18 wks, were fed a regular (0.7o/o NaCl) or a high (8% NaCl) salt 
diet for 6 weeks. BP, heart rate, pulse pressure and activity levels were recorded by 
telemetry. Results were calculated for the 12h light, 12h dark and total24h periods. 
Results: eNOS-KO mice exhibited an augmented basal BP and a heightened level ofBP 
salt sensitivity. C57 mice displayed a slight degree of BP salt sensitivity. The effects of 
salt were more pronounced in the dark phase of the day perhaps reflecting the nocturnal 
nature of mice 
Conclusion: eNOS-KO mice have a higher basal BP and BP salt sensitivity than the 
control strain. 
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Chapter 1: Introduction 
1.1 Hypertension: 
1.1.1 Definition 
Hyperte~sion IS defined as a chronic nse in arterial blood pressure (BP) 
(Goldman, 1999; Safar, 1996). Hypertension is a risk factor for many forms of 
cardiovascular disease such as myocardial infarctions, angina, stroke, and retinal and 
kidney damage, and is a leading cause of death in the Western world (Lilly, 1998; 
Swales, 1994). 
1.1.2 Classification 
The stage and severity of hypertension is normally classified based on the 
person's systolic and diastolic BP. Normal blood pressures are considered to be those 
less than 120/80 mmHg. For every increase in BP of 20/10 mmHg greater than 115/75 
mmHg the risk of cardiovascular disease doubles (Chobanian et a1, 2003). For 
classification on the levels of pre-hypertension and hypertension see table 1 (American 
Heart Association, 2004a). Hypertension affects about 1 billion people world wide 
thereby making it a serious problem in today's culture (American Heart Association, 
2004). 
Both genetic and environmental factors play a role in the development of primary 
hypertension. Environmental factors include a stressful lifestyle, a high salt diet, 
excessive alcohol intake, and obesity (Goldman, 1999). A combination of several genetic 
1 
Table 1: Classification of Hypertension 
Classification of blood pressure based on the American Heart Association 
recommendations (American Heart Association, 2004a). 
Category Systolic Blood Pressure Diastolic Blood Pressure 
(mmHg) (mmHg) 
Normotensive <120 <80 
Prehypertensive 120-139 80-89 
Hypertension (stage 1) 140-159 90-99 
Hypertension (stage 2) 160 + 100+ 
2 
factors involving alterations in the sympathetic nervous system, the renin-angiotension 
system, endothelial function, and abnormal sodium management by the kidney may also 
contribute to the development ofhypertension (Antman, 2002; Genazzani, 2001; Kaplan 
& Lieberman, 1998; Robertson & Ball, 1994). While salt is an example of an 
environmental factor affecting hypertension, it also interacts strongly with the genetic 
determinants of hypertension. High salt consumption is prevalent in the modern diet. 
The combination of a high salt intake and an impaired ability to excrete a salt load may 
contribute to the development ofhypertension (Roman, 1986). 
1.2 Salt Sensitivity and Hypertension 
1.2.1 Definition 
Salt sensitivity refers to a change in BP that is directly related to a change in salt 
intake. A significant rise is considered to be about 10 mmHg or 10% increase in BP 
when the daily intake of sodium increased from normal (109 mmol or 2.5g Na/day) levels 
to a high salt diet (e.g. 249 mmol or 5.7g Nalday) (Weinberger, 1996; Kimura & Brenner, 
1995). Individuals who are salt sensitive respond differently to a high salt diet than do 
those who are termed salt resistant. Salt resistant people experience little or no change in 
BP when the dietary salt intake is increased. In 1989, Hollenberg and Williams reported 
that up to 50-60% of people with hypertension are salt sensitive. Several mechanisms 
have been proposed to explain the different BP responses to salt among the two groups 
and epidemiological studies have been conducted to correlate BP with the level of dietary 
salt intake. 
3 
1.2.2 Salt Consumption 
The risk of cardiovascular disease is augmented in individuals that exhibit salt 
sensitivity. The high level of salt in a typical North American diet places people at risk 
because of the potential salt-induced augmentation of BP. BP's above 115/75 mmHg 
have been shown to increase the risk of death and illness (Chobanian et al, 2003). A high 
salt diet also increases the risk of cardiovascular mortality in hypertensive individuals 
independent of an additional rise in BP (Tobian, 1991). The high prevalence of salt 
sensitive hypertension arises in part from the difficulty of eating a low salt diet in a 
developed country. The high salt content of processed food and the majority of 
restaurant food, regardless of whether or not it is "fast food", as well as the "continual 
presence of the salt shaker" all contribute to a dietary salt intake that is much higher than 
in historical hunter gatherer societies. Thus, a salt sensitive person can develop an 
increased BP from merely eating a typical diet in today's society. That is, salt sensitive 
hypertension does not necessarily arise from a person eating a diet that is higher in salt 
than his/her counterparts. It simply requires a 'normal' salt intake. 
Today, typical North American salt intakes exceed those previously consumed by 
earlier generations and greatly exceed those of some current hunter gather societies. In 
Paleolithic times, the population consumed as little as 1g NaCl (0.4g Na) per day (1g of 
NaCl is about 38% Na by weight) (MacGregor & Wardener, 1998). In societies in which 
the daily salt intake is less than 50 to 100 mmol (1.15-2.3g of NaCl) the presence of 
hypertension and resulting illnesses are rare (Weinberger, 1996). Epidemiological 
studies have suggested that as the average salt intake intensified so did the prevalence of 
cardiovascular disease (Weinberger, 1996). 
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Today an average American has a daily salt intake of about 1 Og NaCl 
( ~ 1 70mmol) (Watanabe et al, 2002; Mancilha-Carvalho et al, 1989) but the 
recommended adequate daily intake is only l.Sg of Na per day (65mmol) (National 
Academy of Sciences, 2004). The recommended tolerable upper limit (UL) is 5.8g of 
NaCl per day (National Academy of Sciences, 2004). Despite this, 90% of Canadian 
men and 50% of Canadian women consume more than this level (National Academy of 
Sciences, 2004). If the typical person consumed the recommended amount of salt they 
would meet their nutritional requirement but also greatly reduce their risk of salt-induced 
hypertension. 
1.2.3 Epidemiological studies 
In an attempt to provide a correlation between dietary salt levels, BP and 
cardiovascular mortality, numerous epidemiological studies have been conducted 
including the Solomon Islands study, the Intersalt study and the DASH (Dietary 
Approaches to Stop Hypertension) study. 
An early epidemiological study that focused on the effects of salt on BP was 
conducted by Page et al (1974). It specifically examined the BP and salt intakes of the 
people living on the six Solomon Islands. Of the six groups examined the general results 
indicated that the more acculturated the society, the greater the salt intake and the higher 
the BP (Page et al, 1974). Of particular interest is the Lau subgroup who had an elevated 
salt intake (150-220mEq/day versus a range from <20mEq to 130mEq/day among the 
other groups) and higher systolic and diastolic BP's across both sexes and most age 
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groups (Page et al, 1974). The groups that ingested salt at lower levels showed no 
increase in BP with age independent of factors such as weight (Page et al, 1974). The 
results from this study clearly indicated that the rise in BP with age is not a 
predetermined event in the time course of a human lifespan. The process of 
acculturation, and specifically the change in diet to a higher salt intake, was suggested to 
be the underlying cause of the current age related upward BP trend (Page et al, 1974). 
The Intersalt study was conducted in the 1980's in response to a lack of 
standardized data on BP in different countries (Intersalt Cooperative Research Group, 
1988). The Intersalt study examined a total of 52 groups across 32 countries. Four 
hundred people, half male and half female, were recruited at random at each test center. 
Each person provided urine samples, body mass information and alcohol consumption 
levels and had their BP measured by trained personnel. Only 4 of the 52 test centers had 
average sodium intake levels that were low enough to eliminate hypertension or 
undesired increases in BP with age. The other 48 groups had an average sodium intake 
of approximately 9 grams of NaCl per day (154mmol NaCVday). Among them, the 
increased salt intake was related to a higher incidence of hypertension and cardiovascular 
related death (Stamler, 1997; Mancilha-Carvalho et al, 1989; Intersalt Cooperative 
Research Group, 1988). The Intersalt study estimated that if the sodium intake was 
reduced by 1 OOmmoVday (e.g. from 150mmol to 50mmol) then the mean BP would drop 
by 2-3 mmHg and the age related increase in BP would drop by about 9 mmHg (Stamler, 
1997; Intersalt Cooperative Research Group, 1988). A drop of2-3 mmHg is predicted to 
correspond with a decrease in cardiovascular mortality and morbidity of about 3-14%, 
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and a drop of 9 mmHg is predicted to correspond with a 13-23% reduction (Stamler, 
1989). 
Urinary sodium excretion (used to estimate the salt intake levels) ranged in 
varying populations from 0.2 mmol/d in the Yanomamo Indians (Brazil) to 242 mmol/d 
in northern China (Intersalt Cooperative Research Group, 1988). The inhabitants of St. 
John's, Canada excreted about 184 mmol sodium/d (Intersalt Cooperative Research 
Group, 1988). The Yanomamo Indians (0.2mmol NaCl/d or <0.01g NaCl), Xingu 
Indians (5.8 mmol NaCl/d or 0.3g NaCl), Papua New Guinean (26.8 mmol NaCl/d or 
1.5g NaCl) and the Kenyans (51.3 mmol NaCl/d or 3g NaCl) had no negative salt related 
changes in BP (Mancilha-Carvalho et al, 1989; Intersalt Cooperative Research Group, 
1988). The average systolic BP of these four groups was 103 mmHg (Mancilha-Carvalho 
et al, 1989). In comparison, the average systolic BP of the remaining 48 groups was 120 
mmHg (Mancilha-Carvalho et al, 1989). Hypertension and related diseases were absent 
in the four low salt groups and increased to 33.5o/o in the 48 high salt groups studied 
(Stamler, 1997; Intersalt 9ooperative Research Group, 1988). 
The Dietary Approaches to Stop Hypertension (DASH) study also assessed the 
effect of salt on BP. The original DASH study examined the effect of a control diet 
(typical western diet), a diet high in fruits and vegetables or a combination diet that was 
high in fruits and vegetables and low in dietary fats (Svetkey et al, 1999). The findings 
indicated that the combination diet was most effective in lowering BP with reductions in 
BP of 1lmmHg (systolic) and 5.5 mmHg (diastolic) without any salt intake restrictions or 
weight loss (Svetkey et al, 1999). The DASH-sodium study examined the effects of 
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sodium intake with either a combination diet or a typical western diet. This study 
confirmed the benefits of the DASH combination diet but, more importantly, it provided 
concrete evidence that a moderate reduction in salt down to <1.15g NaCl /day 
significantly lowers BP (Fleet, 2001). In participants consuming the western type diet, a 
change from high (3.45g NaCl/day) to low (1.15g NaCl/day) sodium intake was 
associated with a decrease in systolic BP of 6. 7 mmHg. In comparison, a person 
consuming the combination DASH diet showed a decrease in systolic BP of 3.0 mmHg 
when their dietary intake was changed from a high to low dietary salt intake (Fleet, 
2001). These results show that although the DASH combination diet is effective in 
controlling BP, the restriction of salt plays an equally significant role in BP control. The 
expansion of the original DASH study to include varying levels of salt emphasized the 
importance of sodium restriction as a method to control hypertension. The DASH-
sodium study provided evidence to support the concept that sodium restriction was more 
effective in controlling BP than the individual effects of the tested diets (Fleet, 2001). 
Taken together, the epidemiological studies provide evidence for the important role of 
salt in controlling and elevating BP. The exact mechanism and time course through 
which salt raises BP is unknown but several theories have been proposed. 
1.3 Studies of Salt Sensitivity in Humans 
Salt sensitivity in man is evident as a change in BP when the dietary salt intake is 
altered. In humans, for ethical reasons, a decrease in salt intake is typically used to test 
for salt sensitivity. Epidemiological studies (described above) have demonstrated that 
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increases in BP observed with age (generally considered 'normal' in Western societies) 
do not exist in societies with a low dietary salt intake (Stamler, 1997; Mancilha-Carvalho 
et al, 1989; Intersalt ~ooperative Research Group, 1988). This suggests that a slow, 
progressive salt sensitivity ofBP is common in developed cultures consuming high levels 
of dietary salt. However, rapid changes in BP can also be observed with acute changes in 
salt intake. 
Short term studies have examined the effect of salt on humans over periods 
ranging from 4 hours to about 1.5 weeks. Luft et al (1979) looked at the effect ofvarying 
levels of high salt intake over 3 day periods and found that increased salt intake (from 
300mmol/d to 1500mmol/d) elevated BP. The responses to the high salt diet showed an 
increase in BP ranging from 1.5-34o/o, demonstrating variability in individual responses 
to salt. Over a shorter time span, Weinberger et al (1986) examined the effects of salt 
and volume infusion over a 4 hour period on the first day and the effects of induced salt 
and volume depletion the following day. They classified salt sensitive people as having a 
change in BP of 10 mmHg or greater and salt resistant people as having a 5 mmHg 
change or less in response to salt infusion and depletion (Weinberger et al, 1986). These 
studies provide evidence for a relatively rapid BP response to a high salt intake. The 
epidemiological data and the results of the short term studies demonstrate that humans 
have both a short term and long term BP response to a high salt diet. 
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1.4 Salt Sensitivity in Animals 
Animal studies have demonstrated salt sensitivity over a wide range of time 
courses and in a number of species. The long term effects ofhigh salt intakes on BP have 
been examined in several studies. 
In 1948, Lenel et al examined the BP of chickens exposed to control (tap water), 
0.9% and 1.2% NaCl in the drinking water. Systolic and diastolic pressures progressively 
increased and were 51 and 3 7 mmHg respectively above the control BP levels after 70 
days of salt intake (Lenel et al, 1948). Meneely et al (1953) examined the effect of2.8, 
5.6, 7.0, 8.4 and 9.8% NaCl feed on BP in Sprague-Dawley (SD) rats over the course of9 
months. Increases in dietary NaCl content elevated BP with the largest increase being 
-25mmHg above control levels (Meneely et al, 1953). However, the BP recordings 
provided excellent long term data but no information on the time course of the response. 
Dahl et al (1968) examined the effect of salt on salt-sensitive rats that had been 
selectively bred from SD rats. The rats were placed on 0.4, 1, 2, 4 or 8% NaCl feed for a 
period of 1 year. BP measurements were taken every month starting from 4 weeks of 
age. BP increased with elevated salt intake. An 8% NaCl diet caused the average 
systolic BP to rise from 14 7 to 210 mmHg (Dahl et al, 1968). 
Cherchovich et al (1976) studied the effect of dietary salt in Papio hamadryas 
(monkeys) over 1-1.5 years. BP increased in response to a high salt (4% NaCl) diet. The 
earlier the age of frrst exposure to high salt, the greater the overall rise in BP 
(Cherchovich et al, 1976). Denton et al (1995) studied the BP of chimpanzees that were 
fed a high salt diet for 20 months (5 g/day for 19 wks, 10 g/day for 3 wks and 15 g/day 
10 
for 67 wks). At the end of the experiment the average systolic BP of salt sensitive 
animals had risen by 33 mmHg and the diastolic BP by 10 mmHg 
A long term study was conducted on mice by Ebihara and Martz in 1971. The 
Cox/Swiss strain of mice was provided with 1% NaCl drinking water for 10 weeks and 
BP measurements were taken once a week using the tail-cuff method (Ebihara & Martz, 
1971). BP gradually increased to about 30 mmHg above control levels after 10 weeks 
(Ebihara & Martz, 1971). Gros et al (2002) used tail-cuff to measure BP in order to 
determine the effect of either a normal or 8% salt diet on BP in C57Bl/6 mice. BP 
measurements began after 2 weeks of exposure and the experiment showed that male 
mice experienced an 18% average increase in BP when exposed to a high salt (8% NaCl) 
diet for 3 weeks (Gros et al, 2002). These studies support the idea that an augmented 
dietary salt intake has a long term, progressive effect on BP. 
Short term studies have examined the rapid response of BP to a high salt intake in 
dogs subjected to a 2/3 renal mass reduction in order to induce salt-sensitivity (Manning 
et al, 1979; Coleman et al, 1969). Coleman et al (1969) had a 7 day control period after 
which the dogs were either allowed to drink saline ad lib or were infused intravenously 
with saline at a constant rate for 2 weeks. Both group showed significant increases in BP 
over the 2 week period with the elevations in BP being higher in animals infused with 
saline (Coleman et al, 1969). Both groups of dogs showed an initial abrupt rise in BP 
over the first week followed by slower progressive elevations in BP during the second 
week. Manning et al (1979) used an 8 day control period followed by a 13 day exposure 
to saline infusion. An initial and rapid elevation in BP of about 20 mmHg in response to 
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salt loading was observed on day 1 of exposure (Manning et al, 1979). This increase 
persisted during the course of the saline infusion and was followed by a further rise of 
about 10 mmHg over the next 12 days (Manning et al, 1979). 
Gross et . al (2000) examined short term changes in BP in mice of a mixed genetic 
background (mostly C57Bl/6) using abdominal telemeter implants over 7 weeks. The 
high salt diet (4% NaCl) was given for about 1 week before the animals were exposed to 
a deoxycorticosterone (DOCA) tablet placed under their skin (Grosset al, 2000). In the 1 
week time frame there was no effect on BP in the mice (Gross et al, 2000). In contrast, 
Carlson and Wyss (2000) examined BP in C57 mice using telemetry. The mice were 
given 1 week to recover from the telemeter implantation, followed by 4 days of control 
BP recordings. The diet was then switched to 8% NaCl and the mice were allowed to 
adapt to this salt level for 1 week after which BP was recorded for 4 days. The high salt 
diet caused a significant increase in BP of about 9 mmHg (Carlson & Wyss, 2000). This 
is relevant to the objectives of the present study because it uses telemetry to measure BP 
in C57 mice. However, the study did not document the initial salt response (week 1) or 
the time course of the BP changes to a high salt diet. 
Although fast and slow BP responses have been described, there is still very little 
data available on the chronology of BP changes in response to salt intake. Van Vliet et 
al. (2005) suggested that the time course of the BP response to a high salt intake in Dahl 
salt sensitive rats has two distinct phases. The first response is a significant rapid rise in 
BP that is then followed by a slow gradual rise in BP. Since the two phases can be 
separated in crossbred rats, they may have different underlying mechanisms. Thus, it is 
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important to consider the time course when evaluating salt sensitivity in an animal model, 
including the knockout mice of our present study. 
1.5 Mechanisms of Salt Sensitivity 
Many physiological systems have been implicated in salt sensitive hypertension. 
The central nervous system as well as the kidney and nitric oxide system have been 
shown to play important roles in the development of high BP as a result of a high salt 
diet. There is evidence indicating that each of these systems plays a role in altering BP in 
response to salt intake and that alterations in multiple systems may contribute to the 
development of salt sensitive hypertension. 
1.5.1 The Kidney 
Salt sensitivity is at least partly dependent on the kidney and its function. Dahl et 
al (1972) and Morgan et al (1990) demonstrated the importance of the kidney in salt 
sensitivity by transplanting kidneys from Dahl salt-sensitive to salt-resistant rats. Their 
results showed that the mechanisms promoting a large part of the hypertensive response 
to salt ingestion were intrinsic to the kidney itself (Morgan et al, 1990; Dahl et al, 1972). 
Morgan et al (1990) demonstrated the involvement ofboth renal and non-renal factors by 
transplanting kidneys between Dahl salt sensitive and salt resistant rats and then feeding 
the rats high salt (8% NaCI) for 2 weeks. Both salt resistant rats with salt sensitive 
kidneys (DRS) as well as salt sensitive rats with salt resistant kidneys (DSR) showed 
augmented BP in response to salt (Morgan et al, 1990). Dahl salt resistant rats with two 
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salt resistant kidneys had an average BP of 103 mmHg, where as DRS rats had a BP of 
approximately 145 mmHg. DSR rats had a BP of about 151 mmHg while Dahl salt 
sensitive rats with two salt sensitive kidneys had an average BP of 160 mmHg (Morgan 
et al, 1990). lt_1 this experiment the kidney's role was demonstrated in the DRS rats 
whereas the importance of non-renal factors was shown in the DSR rats. 
The intrinsic ability of the kidneys to regulate sodium excretion may play an 
important role in the development of salt sensitive hypertension. Several studies have 
shown that Dahl salt sensitive rats excrete lower levels of sodium than their salt resistant 
counterparts (Vaneckova, 2002; Maude & Kao-Lo, 1982; Roman, 1986; Tobian et al, 
1978). Vaneckova (2002) examined isolated kidneys from 12 week old Dahl salt 
sensitive and salt resistant rats fed a low salt diet. This study showed that Dahl salt 
sensitive rats exhibited a lower sodium excretion than the salt resistant rats which was 
possibly due to differences in tubular re-absorption (V aneckova, 2002). Maude and Kao-
Lo (1982) also showed that Dahl salt sensitive rats excreted less sodium than salt resistant 
rats when fed a high salt (8% NaCl) diet. The pressure natriuresis and pressure 
glomerular filtration rate curves of the Dahl salt-sensitive rats were shifted to the right 
indicating a decreased filtered sodium load (Maude & Kao-Lo, 1982). Roman (1986) 
examined the changes in the pressure natriuresis relationship in Dahl salt-sensitive and 
salt- resistant rats fed either a control (0.3% NaCl) or high salt (8% NaCl) diet for 4 
weeks. This study found that Dahl salt-sensitive rats on high salt required a higher 
perfusion pressure to maintain normal renal blood flow and had a lower sodium excretory 
capacity than the Dahl salt-sensitive rats on control salt or Dahl salt-resistant rats 
14 
(Roman, 1986). Consistent with the above results, Tobian et al (1978) demonstrated that 
the isolated kidneys of Dahl salt sensitive rats exhibited a respective 52% and 47% 
decrease in sodium excretion at 130 and 160 mmHg when compared to Dahl salt resistant 
rats. The above studies support the idea that salt sensitive hypertension is associated with 
a reduction in the ability of the kidney to excrete sodium. 
In the presence of a reduced ability to excrete sodium, a high salt diet could lead 
to hypertension by way of the renal body fluid feedback mechanism. In salt sensitive 
individuals, a high salt diet is presumed to cause an increase in extra cellular fluid volume 
(ECFV), cardiac output (CO) and BP through volume expansion (Coleman & Guyton, 
1969). An increase in CO causes the mean arterial pressure and the amount of blood 
flow to the tissues to rise. Through whole body autoregulation, the total peripheral 
resistance (TPR) increases which helps return tissue perfusion and CO to normal and also 
greatly limits volume loading (VanVliet & Montani, 2005; Muntzel & Drueke, 1992; 
Coleman & Guyton, 1969). As the CO returns toward control levels, the BP remains 
elevated due to the sustained increase in TPR (Van Vliet & Montani, 2005). The result of 
this is a long term elevation in BP referred to as volume loading hypertension. 
1.5.2 The Central Nervous System 
The central nervous system (CNS) is presumed to play a role in promoting salt 
sensitive hypertension because a number of treatments affecting the CNS have been 
shown to attenuate or prevent salt induced hypertension: blockade of the brain's ouabain-
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like substance (OLS), the brain's renm angiotensin system, and sympathetic system 
activation, and brain lesions. 
The OLS is involved in the brain's activation of the CNS's renin-angiotensin 
system and the subsequent excitation of the sympathetic system. The OLS levels in the 
brain are increased in response to a high salt diet. If the brain's endothelial Na+ channels 
(ENaC) or the OLS are blocked, the expected salt induced rise in BP is eliminated in salt 
sensitive Dahl rats (Wang & Leenen, 2002). Wang and Leenen (2002) determined that 
the blockade of brain ENaCs _only affected the CNS, and not the peripheral, production of 
OLS. 
Huang and Leenen (1994) found that by blocking the OLS, salt sensitive 
hypertension and sympathetic activation were reduced in salt sensitive Dahl rats fed a 
high salt diet. Further studies showed that blocking the OLS (Zhao et al, 2001), the OLS 
and brain angiotensin II (Ang IT) (Huang & Leenen, 1998; Huang & Leenen, 1996), or 
only the brain's renin-angiotensin system (Leenen & Yuan, 2001) abolished salt induced 
hypertension in Dahl salt-sensitive rats. The final effect of the ouabain-Ang II cascade is 
sympathetic hyperactivity which then leads to increased BP (Huang & Leenen, 1999; 
Huang & Leenen~ 1998). Huang et al (2001) compared the level of responsiveness to 
different sodium concentrations in the cerebral spinal fluid and showed that Dahl salt 
sensitive rats have larger increase in BP, HR and renal sympathetic nerve activity as well 
as a greater ouabain response to a given level of sodium than Dahl salt resistant rats. It 
was concluded that salt sensitive rats appear to be more sensitive to changes in levels of 
salt intake and the amount of salt that enters the brain and therefore salt sensitive rats 
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experience a much greater hypertensive effect when fed a high salt diet than salt resistant 
rats. 
Although both the brain and the kidney have been suggested to be key players in 
hypertension induced by a high salt diet, a study by Huang et al (2004) showed that the 
brain registered an increase in salt concentration in the cerebral spinal fluid (CSF) prior to 
an increase in BP or heart rate (HR). This suggests that the brain may be responsible for 
initiating the development of hypertension in response to salt ingestion (Huang et al, 
2004; Gavras, 1986). This is supported by the finding that sympathetic inhibition 
eliminates the salt induced rise in BP observed in salt sensitive animals (Oparil et al, 
1988; Friedman et al, 1979; Takeshita et al, 1979). This demonstrates that an intact 
sympathetic nervous system (SNS) is necessary for the development of salt sensitive 
hypertension in the Dahl salt-sensitive rat model (Leenen et al, 2002; Haung & Leenen, 
1999). That is, blocking the brain's connection with the kidney appears to limit the 
development of salt sensitive hypertension. 
1. 5.3 The Nitric Oxide System 
Nitric oxide (NO) is thought to play a role in the body's normal response to salt 
(Manning et al, 2001; Tolins & Shultz, 1994). The results of several studies suggest NO 
plays a role in the development of salt sensitive hypertension. 
First, a rise in NO production normally occurs in response to an increase in 
dietary salt intake (Kiraku et al, 1999). In normal mice fed a high salt diet the urinary 
excretion of NO metabolites increased along with the BP (Kiraku et al, 1999). Tolins and 
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Shultz (1994) similarly demonstrated that when SD rats were placed on a high salt (4% 
NaCl) diet their excretion of NO metabolites was enhanced. 
Second, the increase in NO production with high salt appears to be attenuated in 
salt sensitive hypertension. Manning et al (200 1) demonstrated that Dahl salt sensitive 
rats had a lower urinary excretion of NO metabolites than their salt resistant counterparts. 
Ni et al (1999) and Ni & Vaziri (2001) showed that Dahl salt sensitive rats consuming a 
high salt diet had a lowered expression of inducible nitric oxide synthase (iNOS) and 
endothelial nitric oxide synthase (eNOS) and a higher expression of neuronal nitric oxide 
synthase (nNOS) than salt resistant rats. These studies suggest that there is attenuated 
production of NO by eNOS with increased salt intake in salt sensitive rats (Manning et al, 
2001; Kiraku et al, 1999). 
Third, inhibition of NO production leads to salt sensitive hypertension. Several 
studies have shown that the administration of a nitric oxide synthase (NOS) inhibitor to 
rats results in salt sensitivity: i.e. a rise in BP when placed on a high salt diet {Tan et al, 
2000; Rudd et al, 1999; Yamada et al, 1996; Tolins & Shultz, 1994). A study by Tolins 
and Shultz (1994) showed the significance ofNO in the regulation of sodium and BP. By 
comparing SD rats fed a high salt diet (4% NaCl) or a high salt diet and L-NAME, it was 
shown that BP control was possible as long as the NO system remained intact {Tolins and 
Shultz, 1994). The control SD rats on a salt diet had an increased urinary excretion of 
NO metabolites while BP remained normal (Tolins and Shultz, 1994). In contrast, rats 
fed both salt and L-NAME showed a rise in BP with no increase in urinary excretion of 
NO metabolites {Tolins and Shultz, 1994). Rudd et al (1999) also concluded that NO is 
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required for normal BP control. When Dahl salt sensitive rats were placed on a high salt 
(8% NaCl) diet and given a NOS inhibitor {AMT), their BP rose significantly above the 
levels seen on the high salt diet alone (Rudd et al, 1999). Obst et al (2004) used mice 
implanted with . telemeters to monitor BP to show that NOS inhibition via L-NAME 
combined with a high salt intake led to a rise in mean arterial pressure (MAP) that was 
directly related to an increase in TPR. TPR was taken to be the quotient of MAP and CO, 
with CO being measured using a Transonic flow probe (Obst et al, 2004). Irrespective of 
the exact mechanism involved, the results of these studies suggest that NO is important in 
BP regulation and salt sensitive hypertension. 
A fourth and final argument for the importance of NO is that increases in NO 
production can lead to the correction of salt sensitivity (Manning et al, 2001; Miyata & 
Cowley, 1999). In Dahl salt-sensitive rats, the administration of L-arginine can restore 
the amount of urinary NO metabolites to the level seen in salt-resistant rats (Manning et 
al, 2001 ). At the same time, it eliminates the effect of salt on BP in this model (Manning 
et al, 2001). Miyata & Cowley (1999) demonstrated that intra-renal medullary 
administration of L-arginine was sufficient to eradicate salt induced hypertension in Dahl 
salt-sensitive rats, suggesting a critical NO deficiency may be present within the renal 
medulla. The ability of L-arginine to reduce salt sensitivity in Dahl salt sensitive rats 
likely stems from the presence of endogenous NOS-inhibitors that compete with L-
arginine, such as ADMA. ~' W-dimethyl-L-arginine) (Matsuoka et al, 1997). Since L-
arginine is a substrate for NOS, increasing its concentration in the body would help 
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overcome this competitive inhibition and thus help increase the production ofNO (Boger, 
2004; Masuda et al, 2003; Leiper & Vallance, 1999). 
1.6 Nitric Oxide Synthase 
NOS is the enzyme that catalyzes the production of NO in the body. There are 
three different isoforms of NOS: eNOS or NOS III, iNOS or NOS II and nNOS or NOS I. 
In addition to the regulation of BP, NO influences many other physiological processes 
such as inflammatory responses, immune control, blood volume control and pressure 
natriuresis, and neurotransmission in the brain and peripheral nervous system (Kone, 
2004; Lirk et al, 2002; Torreilles, 2001; Kubes, 2000; Person et al, 2000; Yun et al, 
1997). 
1.6.1 Inducible Nitric Oxide Synthase 
The main roles of iNOS involve inflammatory responses and immune functions. 
iNOS, the gene of which is located on chromosome 17 of the human genome, is 
necessary for normal healing of the skin, removal of certain bacteria, viruses, fungi and 
parasites, and for T cell proliferation and leukocyte recruitment in immune responses 
(Kone, 2004; Lirk et al, 2002; Torreilles, 2001; Kubes, 2000). 
iNOS has also been shown to be also expressed in the medullary region of the 
kidney where it appears to play a role in the development of salt sensitive hypertension 
(Rudd et al, 1999; Morrissey et al, 1994). Increasing its expression in the renal medulla 
causes a decrease in BP (Kurihara et al, 1998). In Dahl salt resistant rats, the 
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administration of selective iNOS inhibitors (e.g. aminoguanidine) caused an increase in 
BP when the rats were consuming a high salt (8% NaCl) diet (Tan et al, 2000; Rudd et al, 
1999; Chen & Sanders, 1993). The chronic inhibition of iNOS with aminoguanidine in 
SD rats on a high salt diet produced an increase in BP, a decrease in urinary flow and 
increase in body weight due to water retention (Mattson et al, 1998). This data suggests 
that iNOS may play a role in maintaining a normal BP when on a high salt diet. 
Induction of iN OS production has the opposite effect of iN OS inhibition. Ishimitsu et al 
(1994) used interleukin-2 to increase the expression of iNOS and discovered that a 
decrease in BP was produced even when the rats consumed a high salt (4% NaCl) diet. 
Cowley et al (1995) suggested that a reduction in renal medullary blood flow was 
partly responsible for the development of hypertension during NOS inhibition. L-NAME 
was administered directly into the medullary region causing an increased re-absorption of 
sodium and water and a rise in BP (Cowley et al, 1995). Since iNOS is the main form of 
NOS located in the renal medulla (Mattson et al, 1998), it was proposed that this isoform 
was at least partly respqnsible for the effect of NOS inhibitors administered to this 
region. It was suggested that the inhibition of iN OS produced a greater renal medullary 
re-absorption of salt and water, leading to a rise in ECF volume and BP. If the 
expression of iNOS was enhanced then a greater amount of salt and water would be 
excreted via the kidney and the BP would decrease. These findings suggest that iNOS 
has an important role in salt and water re-absorption/excretion and impairment of its 
normal functioning may contribute to salt sensitive hypertension. 
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1.6.2 Neuronal Nitric Oxide Synthase 
nNOS, the gene of which is located on the 12th human chromosome, is widely 
expressed in the brain, peripheral nervous system, renal efferent arterioles and the macula 
densa (Boron & Boulpaep, 2003; Torreilles, 2001; Braam et al., 2000; Kubes, 2000; 
Rudd et al, 1999; Kurtz & Wagner, 1998; Yun et al, 1997). In the brain, it is thought to 
help regulate sympathetic output to the periphery (Krukoff, 1998). In neurons, NO is 
thought to act as a messenger molecule or neurotransmitter, aid in neuronal development 
and help regulate synaptic plasticity and gene expression (Yun et al, 1997). In the 
macula densa, it is thought to play a role in renin release and possibly tubuloglomerular 
feedback (TGF) (Braam et al, 2000; Braam, 1999; Rudd et al, 1999). 
Tan et al (1999) described that salt resistant Dahl rats treated with the selective 
nNOS inhibitor 7-nitroindazole (7NI) exhibited a significant increase in BP when placed 
on a high salt diet. A decrease in nNOS could affect the BP in many ways, including an 
effect on the CNS to increase sympathetic activity or a direct effect on the macula densa 
to alter the release of renin by the kidney, or influence the TGF (Tandai-Hiruma et al, 
2005; Tan et al, 1999). 
While the nNOS system has been suggested to contribute to the regulation of 
renin secretion and synthesis (Braam et al, 2000; Braam, 1999; Beierwaltes, 1997), the 
exact role of nNOS in the process of renin secretion is a matter of controversy (Castrop et 
al, 2004; Ollerstam et al, 2001; Wagner et al, 2000). Several studies support the idea that 
nNOS is mandatory for the secretion of renin. Reviews by Braam (1999 & 2000), 
support the concept that nNOS system is linked to long term changes in the delivery of 
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sodium to the macula densa and salt excretion. It was suggested that increases in salt 
delivery to the macula densa promoted a decrease in nNOS activity and renin release 
(Braam, 1999). Since nNOS and renin levels change simultaneously it has been 
suggested that nNOS may be involved in both the production and secretion of renin. The 
above views were based on the results of Beierwaltes (1997) who showed that chronic 
inhibition of nNOS with 7NI in SD rats fed a low sodium (0.03% NaCl) diet resulted in 
decreased renal venous renin concentration and secretion. In contrast, rats fed a normal 
(0.2% NaCl) or low sodium diet under conditions ofnNOS inhibition showed no changes 
in renin levels or production (Beierwaltes, 1997). These findings support the idea that 
nNOS may directly influence the production or excretion of renin. 
Several studies suggest that NO, irrespective of which NOS isoform it is produced 
by, must be present for the stimulation of renin secretion (Castrop et al, 2004; Ollerstam 
et al, 2001; Wagner et al, 2000). Wagner et al (2000) suggested that NO derived from L-
arginine by the actions of nNOS was not ultimately responsible for renin secretion. 
Evidence from the latter study showed that nNOS knockout mice did not have a reduced 
basal level of renal renin compared to controls (Wagner et al, 2000). However, during 
acute treatment with L-NAME, renin mRNA decreased in both nNOS knockout mice and 
their controls (Wagner et al, 2000). Ollerstam et al (2001) also reported that nNOS had 
acute, but not chronic effects, on renin secretion. SD rats were fed a low salt (0.012% 
NaCl), control (0.7% NaCl) or high salt (4% NaCl) diet and were treated with either a 
placebo or 7NI for an acute ( 4 day) or chronic ( 4 week) time period. Acute treatment 
with 7NI lead to elevated renin levels in rats fed low salt. No differences were observed 
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between the control or high salt diet rats in either the acute or chronic time periods and no 
differences were observed in the low salt diet rats in the chronic administration of 7NI. 
Castrop et al (2004) reported that the stimulation of renin secretion by loop diuretics was 
not markedly altered in either nNOS or eNOS knockout mice. This supports the idea that 
NO may be required for renin secretion, but renin secretion is unaffected by the specific 
NOS isoform producing the NO. To further support this idea, L-NAME, a non-specific 
inhibitor of NO, was injected into isolated kidneys along with exogenous NO (S-nitroso-
N-acetyl-penicillamine) (Castrop et al, 2004). While L-NAME decreased the response of 
renin in the presence of loop diuretics, the addition of exogenous NO restored the normal 
response (Castrop et al, 2004). Thus, NO may simply have a permissive role in renin 
secretion. 
The NO system also plays a role in TGF (Braam et al, 2000). NO appears to be 
important in the resetting of the TGF to lower sensitivity levels in the face of volume 
expansion (Brown et al, 2004). By resetting the TGF to lower sensitivity levels, more 
fluid is able to flow past ~he macula densa cells before the feedback loop is activated and 
decreases glomerular filtration rate (GFR). This increase in distal fluid delivery helps 
increase salt excretion and therefore helps re-establish salt balance to maintain the desired 
ECFV. Although it is unknown exactly which NOS isoform is responsible, nNOS is 
likely involved. nNOS, present in the cells of the macula densa, may be stimulated by an 
increase in delivery of fluid and sodium to the macula densa (Brown et al, 2004; Braam 
et al, 2000). Brown et al (2004) examined the effect of either L-NAME or 7NI in volume 
expanded SD rats and found that the effect on TGF was similar with both the specific and 
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non-specific NOS inhibitor. The study reported that in the presence of volume expansion 
and a nNOS inhibitor, there was an increase in the sensitivity and reactivity of the TGF 
system rather than the decrease in sensitivity seen in the absence of an NO inhibitor 
(Brown et al, 2q04). This resulted in the TGF system being more easily activated (i.e. by 
a lower fluid flow past the macula densa) enabling it to produce a decrease in GFR. This 
increase in sensitivity would promote fluid retention and volume loading and suggests 
that NO (produced by nNOS activity) is necessary for the control of TGF during volume 
expansion (Brown et al, 2004). 
The results of several studies suggest that it is the altered sensitivity or 
responsiveness of the TGF system that causes volume expansion to occur and BP to rise 
in animals that are developing hypertension (Persson et al, 2000). NOS was suggested to 
play an important role in keeping the sensitivity of the TGF constant, therefore helping to 
control BP (Brown et al, 2004; Braam et al, 2000; Braam, 1999). The non-selective 
NOS inhibitor L-NAME has been suggested to cause an increased TGF sensitivity and 
BP (Persson et al, 2000; Thorup et al, 1996). In order to determine if a specific isoform 
of NOS affects the TGF, the selective nNOS inhibitor 7NI was used to determine the 
specific contribution of nNOS (Persson et al, 2000; Thorup et al, 1996). Through the use 
of 7NI, it was suggested that nNOS was likely responsible in governing the sensitivity of 
the TGF system and the resulting changes in BP (Persson et al, 2000; Thorup et al, 1996). 
Other studies suggest that nNOS is only vital in the regulation of the TGF in acute 
conditions (Ollerstam & Persson, 2002). Ollerstam et al (1997) looked at the effect of 
nNOS inhibition with 7NI over acute and chronic time frames in SD rats. Initially, the 
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TGF sensitivity was increased and there was a decrease in GFR, but after 1 week the 
effect of the nNOS inhibitor was lessened and the sensitivity of the TGF was returning 
toward normal levels. After 4 weeks of exposure to 7NI, the TGF sensitivity was similar 
to control rats not exposed to nNOS inhibitors. Ren et al (2001) also provided evidence 
for the short term influence of nNOS on TGF using nNOS knockout mice. nNOS 
knockout mice showed similar TGF sensitivity levels to their control wild type mice (Ren 
et al, 2001). Whereas, when the control mice were given 7NI to inhibit nNOS they 
showed an increased sensitivity of the TGF (Ren et al, 2001). These findings suggest that 
although nNOS plays an important role in resetting the TGF sensitivity, the influence 
may only be acute and temporary. 
nNOS may also affect BP through its interaction with the sympathetic nervous 
system. As previously discussed, sympathetic nerve hyperactivity may contribute to salt-
induced increases in BP. Spontaneously hypertensive rats (SHR) have been shown to 
have increased renal sympathetic nerve activity and increased sympathetic reactivity 
when compared to control normotensive rats (Li et al, 1997; Lundin et al 1984). A 
review by Krukoff(1998) suggested that NO produced via nNOS in the brain is involved 
in limiting the amount of sympathetic output reaching the periphery. By decreasing the 
sympathetic nerve output, nNOS may play a role in regulating the amount of sympathetic 
hyperactivity and therefore BP. Plochocka-Zulinska & Krukoff (1997) demonstrated an 
increase in nNOS gene expression in the brains of SHR's compared to Wistar-Kyoto 
normotensive rats at 14 weeks of age. They postulated that the increase in nNOS 
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expression was required to return the increased sympathetic hyperactivity back to normal 
levels thus lowering the BP (Plochocka-Zulinska & Krukoff, 1997). 
Other studies emphasize the importance of brain nNOS. Togashi et al (1992) 
administered L-;NAME into the CNS of Wistar rats and reported an increase in BP and 
sympathetic nerve activity. These results suggest that by eliminating the ability of nNOS 
to regulate the sympathetic outflow (via L-NAME), a resultant increase in sympathetic 
activity and BP occurred. Tandai-hiruma et al (2005) examined the effect of S-methyl-L-
thiocitrulline (a selective nNOS inhibitor) on the renal sympathetic nerve activity 
(RSNA) in Dahl salt sensitive rats fed either a high salt (8% NaCl) or regular salt (0.4% 
NaCl) diet for 4 weeks. A significant increase in RSNA occurred in both groups but was 
significantly greater in the high salt versus the regular salt diet rats (Tandai-hiruma et al, 
2005). In both the regular and high salt diet rats, the administration of L-arginine 
reversed the effects of the nNOS inhibitor (Tandai-hiruma et al, 2005). These studies 
show that nNOS plays an important role in controlling sympathetic nerve activity and 
therefore BP. 
1.6.3 Endothelial Nitric Oxide Synthase 
NO is produced from L-arginine by the actions of eNOS in the endothelial cells 
lining blood vessels. The eNOS gene, which is located on chromosome 7 in humans, 
provides an important contribution to blood vessel tone, systemic and renal hemo-
dynamics, NaCl re-absorption in the renal tubules and endothelial mediated vasodilation 
(Kone, 2004; Ortiz et al, 2003; Torreilles, 2001; Braam et al., 2000). 
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A study by Van Vliet et al (2003) showed that eNOS knockout mice had higher 
24 hour BP's when compared to the control C57 mice. Eliminating eNOS limits the 
body's ability to elicit vasodilation. BP can be increased by elevating vascular tone and 
decreasing flui~ excretion, which will augment ECFV, peripheral resistance and BP. 
eNOS appears to be activated by vasoconstrictors such as angiotensin II as well as by 
shear stress on the blood vessels (Parzak et al, 2001 ). NO may act as a counterbalancing 
mechanism to ensure that excessive levels of vasoconstrictors do not result in the 
production of extreme elevations in BP (Parzak et al, 2001). 
More specific roles of eNOS include regulation of renal vascular tone, including 
that of the afferent arterioles of the glomerulus (Parzak et al, 2001; Gabbai & Blantz, 
1999: Kurtz & Wagner, 1998). In the absence ofNO, with no counter balancing effect in 
place, angiotensin II causes unopposed renal vasoconstriction (Parzak et al, 2001). 
Constriction of the afferent arterioles limits the amount of fluid (salt and water) that can 
be filtered at the glomerulus and reduces the pressure within the peritubular capillaries. 
This promotes an increase in the re-absorption of the tubular fluid and a decrease in salt 
and water excretion as well as an increase in renin release. These alterations ultimately 
can increase ECFV and BP. 
NO has been speculated to play a role in salt and water absorption in the tubules 
of the kidney including the proximal tubule, thick ascending limb and cortical collecting 
ducts (Herrera & Garvin, 2005; Ortiz et al, 2003; Ortiz et al, 2003a; Ortiz & Garvin, 
2002). eNOS is responsible for the inhibition of salt and water re-absorption in the thick 
ascending loop of Henle (THALs), therefore suggesting it plays an important role in fluid 
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balance (Herrera & Garvin, 2005). In the presence of a high salt diet, the expression of 
eNOS in the THALs is increased allowing a greater amount of salt and water to be 
excreted (Herrera & Garvin, 2005; Ortiz et al, 2003a). This could help to reduce the total 
body fluid volume and BP. Ortiz et al (2003a) examined the effect of a high salt diet on 
the eNOS expression in the THALs of SD rats. After 7-10 days of consuming a high salt 
intake (1% NaCl added to the drinking water), eNOS expression in the THALs was 
increased about 3.9-fold over the regular salt rats (Ortiz et al, 2003a). It was noted that 
although the expression of eNOS increased, the level of NO produced in response to a 
lmmol/L injection of L-arginine was the same in isolated THALs from both the regular 
salt and high salt diet mice (Ortiz et al, 2003a). To compensate for the lack of enhanced 
NO production in the high salt diet mice, it was suggested that the sensitivity of the 
THALS to NO was augmented in the presence of a high salt diet (Ortiz et al, 2003a). 
Another study that supports the contribution of eNOS to the regulation of salt and water 
uptake examined eNOS knockout mice and gene transfer of eNOS into the THALs (Ortiz 
et al, 2003). Gene transfer of eNOS caused an elevated production of NO and an 
inhibitory effect on salt re-absorption after about 7-10 days (Ortiz et al, 2003). These 
studies indicate that eNOS in the THALs plays an important role in fluid balance and 
possibly BP control. 
As previously discussed, NO plays an important role in governing renin release. 
Shesely et al (1996) showed that, although the renal renin mRNA levels were lower, 
eNOS knockout mice had higher circulating renin levels than control C57 mice. In 
contrast, Beierwaltes et al (2002) reported that while the BP and HR were higher in 
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eNOS knockout mice than the control mice, the plasma renin levels were similar, 
suggesting that eNOS was not involved in controlling plasma renin levels (Beierwaltes et 
al, 2002). In the latter study, L-NAME caused an increase in BP and renal vascular 
resistance and a decrease in renal blood flow in C57 mice. However, no effect was seen 
in the eNOS knockout mice (Beierwaltes et al, 2002). L-NAME inhibited the increase in 
renin levels in response to decreased perfusion pressure in C57 mice (Beierwaltes et al, 
2002). However, the observation that this response was maintained in eNOS knockout 
mice suggested that NO formed by a non-eNOS isoform was likely involved in 
controlling renin release. Consistent with the above view, Castrop et al (2004) also found 
no difference in the plasma renin concentration in eNOS knockout mice and their 
controls. Although these studies do not support a role of eNOS in mediating renin 
secretion, NO likely plays a permissive role allowing renin secretion to take place 
(Castrop et al, 2004; Kurtz and Wagner, 1998). 
1.7 Rationale 
Salt sensitivity affects a large portion of the developed world where daily salt 
intakes are higher than physiologically required. The modern North American diet is 
characterized by extremely high intake of sodium which consequently increases the risk 
of hypertension and cardiovascular disease. The NO system plays an important role in 
governing salt and water balance. An impaired ability of the body to produce NO may be 
an important contributor to salt induced hypertension in salt sensitive individuals. The 
contribution of each isoform of NOS to salt sensitivity is unclear. Several studies have 
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attempted to use specific NOS inhibitors to study the physiological effect of NO on BP 
and salt and water balance. Although these studies emphasize the importance of NO in 
governing these processes, the lack of specificity of NOS inhibitors limits definite 
conclusions as to the specific role that various NOS isoforms play in BP control and salt 
induced hypertension. In particular, the role of altered eNOS function in the production 
of salt induced hypertension remains unclear as specific eNOS inhibitors are not 
available. In view of this, we attempted to study the effects of salt on BP in eNOS 
knockout mice. 
1.8 Objectives of the study 
In order to investigate salt sensitivity in eNOS knockout mice, we first need to 
understand the characteristics of salt sensitivity in the control C57 strain of mice. Salt 
sensitive hypertension has been shown to develop over both short and long term time 
scales. To assess the time course of salt sensitivity, telemetry experiments were 
conducted in both C57 mice and eNOS knockout mice. 
The main objectives of this study were to determine the effect of a high salt diet 
on the BP, HR, pulse pressure and activity of C57 mice and eNOS knockout mouse. In 
order for these objectives to be achieved, implanted BP telemeters were used to provide a 
detailed description of the time course of physiological changes in response to an 
increase in dietary salt. 
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1.9 Hypotheses 
Several hypotheses were assessed in this thesis project. The first hypothesis is 
that the addition of a high salt diet will cause an increase in BP in C57 mice. Several 
studies have suggested varying levels of salt sensitive in C57 mice (Ni et al, 2003; Gros 
et al, 2002; Sugiyama et al, 2001; Carlson & Wyss, 2000). Our goal is to determine the 
exact level of salt sensitivity exhibited in C57 mice being fed a high salt (8% NaCl) diet 
as well as its time course. The second hypothesis of this thesis is that eNOS knockout 
mice will demonstrate a larger BP response to a high salt diet than seen in the C57 mice. 
An enhanced salt sensitivity in eNOS knockout mice will suggest that eNOS plays a role 
in the body's normal response to an increase in salt intake. 
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Chapter 2: Methodology 
2.1 Materials and Methods: 
2.1.1 Experimental animals 
The experiments were approved by the Memorial University of Newfoundland 
Animal Care Committee. C57 control mice (eNOS+/+, C57Bl/6J, stock no. 000664) and 
eNOS-deficient mice (eNOS -/-, B6.129P2-NOStmtunc, stock no. 002684) were bred 
locally or purchased from Jackson Laboratories. The functionality of the eNOS gene was 
removed by using a targeting construct (pENOSX) to alter the calmodulin binding site by 
placing a premature stop codon along the translation command (Shesely et al, 1996). The 
eNOS (-/-) mice showed an absence of the eNOS protein when immunohistochemical 
staining was performed (Shesely et al, 1996). The eNOS knockout mice also had 
decreased body weights compared to their control but no significant differences were 
seen between the heart, aorta, liver, kidney, brain, spleen or adrenal glands of the two 
strains (Shesely et al, 1996). Jackson laboratories cross bred the eNOS (-/-) strain 
produced by Shesley et al (1996) to the C57Bl/6J strain eight times, which should result 
in a 99.6% homogeneity in the genetic background (Van Vliet et al, 2003). 
Males and females of both strains were housed at the Memorial University 
Animal Care unit from 5 weeks of age. Mice were allowed 3 weeks to adapt to the 
environment during which time they were ear tagged. At 8 weeks of age the animals 
were mated with animals of the same strain (eNOS(-/-) x eNOS(-/-), eNOS(+/+) x 
eNOS(+/+)). The offspring were weaned at 4 weeks of age and ear tagged at 
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approximately 5-7 weeks of age. Mice used in the experiments underwent telemeter 
implantation between 11 and 18 weeks of age. The mice were housed separately about 2 
weeks prior to implantation. 
2.1.2 General husbandry 
Both strains of mice were housed in the same room (breeding room). Following 
the implantation of a telemeter, animals involved in an experiment were housed in a 
separate recording room. The temperature of the breeding room was 25 ± 1 °C to help 
assist with breeding, whereas the temperature of the recording room was slightly lower 
(23 ±0.5 °C). Both rooms were maintained on a 12hr light-dark cycle with lights turning 
on at approximately 7:00am and off at 7:00pm. All mice were fed a standard feed 
containing 0.7% NaCl, 1.0% calcium, 0.91% potassium and 0.75% phosphorus (Lab diet 
SPOO, Prolab). Experimental animals, chosen at random to ingest a high salt diet, were 
fed the same feed with extra salt added to bring the level to 8% NaCl. This level of salt 
has previously been shown to cause changes in blood pressure in mice (Gros et al, 2002; 
Carlson & Wyss, 2000). All animals were provided with new cages on a weekly basis 
and no more than 5 mice (usually 2-3 mice) were housed per cage. Each cage contained 
standard rodent bedding material, a plastic tube and a sheet of paper towel to be used for 
bedding. Food and water intake was calculated from the change in the food and water 
weights from week to week. Mice were checked periodically throughout the week to 
ensure comfort and well being. 
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2.2 Experimental Protocol 
Males 11-18 weeks of age were weighed and giVen a single injection of 
approximately 0.03ml . (0.03ml per 25-30g mouse) of ketamine/xylazine (90/1 0 mg/ml) 
intramuscularly, The necks of anesthetized animals were shaved and the remaining hair 
was removed with a depilatory cream (Nair for Men, Cream Hair Remover for Body, 
Carter-Homer Corp, Canada) that was left on for approximately 4 minutes. Lubrication 
(lubricating jelly, Healthcare Plus, Jedmon Products Limited, Canada) was placed over 
the eyes of each mouse to ensure that they did not experience unnecessary drying. The 
mice were placed on a heated pad (37°C) and their forelimbs were secured to the pad with 
tape. The tails were also secured on the heating pad to help maintain their body 
temperature. The mice were given approximately 0.03ml of atropine (0.5mg/ml) 
subcutaneously to dry up respiratory secretions and to attenuate the xylazine induced 
drop in HR, and approximately a 0.01ml dose of penicillin (300 000 mg/ml) 
intramuscularly to decrease the risk of infection. If necessary, the anesthetic was topped 
up with approximately 0.01ml of ketamine (33mg/ml) to allow the procedure to be 
completed. 
Once the depilatory cream was removed and the pre-medications administered, 
the mice were covered in sterile gauze to help maintain their body heat and maintain a 
clean environment. An incision was made from the mandible to the sternum, the 
submaxillary glands were separated and the left carotid artery exposed using a 
combination of fine and gross dissection. The carotid artery was separated from the 
vagus nerve and three silk ligatures (6.0) were passed under it. The caudal ligature (5.0 
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or 6.0 silk) was not tied but used to retract the vessel to stop blood flow. The second 
ligature was tied loosely and placed near the caudal ligature. The rostral ligature was tied 
tightly twice to permanently occlude blood flow. 
Using gentle tension, the artery was occluded and prepared for the insertion of the 
telemeter's catheter tip. The catheter tip (with the protective cap removed) was grasped 
using specialized forceps and the artery was incised with a bent # 27 or 25 gauge needle. 
Once the catheter tip was inserted, the caudal ligature was loosened and the loosely tied 
ligature was secured around the artery over the catheter. The catheter ridge (an 
indentation in the catheter tubing) was advanced until the ridge was approximately 1 mm 
caudal to the bifurcation of the carotid artery. This location was found to be appropriate 
to position the catheter tip just past the junction of the carotid artery with the aorta. The 
rostral ligature was then tied around the catheter to further secure it. Despite the potential 
limitations of occluding a carotid artery, the carotid implant technique has been widely 
used because it is a successful technique and generally less stressful on the animal 
compared to the abdominal implant technique (Carlson & Wyss, 2000). 
Using large hemostats, a subcutaneous pocket was made in the right side of the 
mouse from the shoulder down to the hip. Sterile saline was used to lubricate the pocket 
to help facilitate the insertion of the telemeter body. Once the telemeter body was 
positioned in the subcutaneous pocket, the incision was closed with suture (6.0 chromic 
gut). Following surgery, each mouse was placed in their original cage that was 
positioned on a heating pad to help mice maintain their body temperature and reduce 
thermogenic energy expenditure. The mice remained on the heating pad for at least 48 
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hours following surgery to ensure optimal recovery. After approximately 72 hours the 
mice were moved to the recording room where they were placed on the telemeter receiver 
plates. For each recording period, the telemeters were turned on at least 12 hours prior to 
the data collection. After 10 to 14 days of recovery the animals telemeters were turned 
on to collect the first 24 hours of control data (Thursday AM- Friday AM). Four days 
later the telemeters were again turned on and allowed to record for 3 more days before 
the experimental mice were switched to 8% salt feed (Tuesday AM- Friday AM). Once 
the change in feed occurred, data was recorded for another 6 days before the telemeters 
were switched off (Saturday AM- Friday AM). Following this, the telemeters recorded 
data for 36 hours per week for another 5 weeks (Wednesday AM- Friday AM). 
Following the last day of recording, the animals were anesthetized using 
ketamine/xylazine (90/1 0 mg/ml), and the telemeters were removed. 
2.2.1 Telemetry 
All telemeter equipment was purchased from D.S.I. The mice were 
implanted with D.S.I model TA11PA-20 telemeters. Data was collected using model 
RLA 1020 receiver plates on a 20 channel data exchange matrix with Dataquest ART 
Silver 2.1 or Gold 2.3 acquisition system. The data was recorded at 500 Hz for 3 seconds 
in 30 second intervals. Every 3 second recording period provided an average BP, HR, 
pulse pressure and activity reading. The activity signal of the telemetry system was 
counted over each 30 second sampling period (Van Vliet et al, 2003). The percentage of 
time spent active was calculated as the number of sample periods with activity counts 
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greater than zero. The level of activity was calculated as the mean of log (activity) when 
activity >0. 
2.2.2 Catheter Tip Placement 
Prior to the removal of the catheter from the carotid artery, but after the telemeter 
body was removed from the subcutaneous pocket, the location of the catheter tip in the 
aorta was determined. The chest cavity was opened and the aorta exposed. A ruler was 
placed near the aorta so that the distance of the tip from the junction of the carotid artery 
and aorta could be calculated. 
2.2.3 Tail and Blood Samples 
Once the telemeters were removed from each mouse a blood sample and a 
segment of the tail were taken. The blood was centrifuged and the plasma was removed. 
The samples were clearly labeled and stored in the freezer. 
2.2.4 Calibration of Telemeters 
Telemeters were calibrated both before and after implantation. The pressure 
readings were taken at atmospheric pressure at room temperature and atmospheric 
pressure and +200 mmHg at 37° C. Two recordings were taken at each pressure and 
temperature. The averages of the recordings taken at 37° and atmospheric pressure both 
before and after implant were used to determine the offset value which was used to 
correct the recorded data. This offset value was inserted into the data analysis program 
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HD stats, an Excel spreadsheet developed by the Van Vliet laboratory for the routine 
analysis of 24 hour telemeter data. The program then automatically applied the offset 
value to the recorded data. 
2.2.5 Aorta Removal and Sheath Examination 
During the course of the experiment it was noticed that one reason why telemetry 
signals occasionally deteriorated with time was the development of a reactive growth 
over the catheter tip. To determine the extent of the growth, upon removal of the catheter 
and telemeter the carotid artery and aorta were removed. A cut was made along the 
length of the aortic arch. The aorta was then opened so that the junction of the two blood 
vessels was exposed allowing any growth that may have been present to be seen. Only 
the data from mice that showed a catheter tip clear of growth and a 24h pulse pressure 
greater than 20 mmHg were used in this study. 
2.3 Statistical Analysis 
Daily telemetry data was inserted in the data analysis program HD stats, an Excel 
spreadsheet developed by the Van Vliet laboratory. From this program, information was 
provided on 24 hr and 12 hr means, standard deviations and ranges for MAP, pulse 
pressure, HR and activity. Minitab 13 (statistical program) was used to test for 
significant differences and relationships between MAP, HR, pulse pressure and activity 
using Analysis of Variance (ANOVA). A general linear model was used to test for 
significant effects of diet (control or high salt), time and genotype. A Dunnet's test was 
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used to compare data at individual time points to the baseline control day 4 (the last day 
of the control period). A Tukey' s test was used to determine differences between groups 
during each phase. An ANOV A was used to compare both the absolute values on day 4 
of the control p~riod and the food and water intakes over the course of the experiment. 
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Chapter 3: Results 
The first part of the Results section will describe the hemodynamic values 
recorded during the control period in the C57 and eNOS knockout mice. Following this, 
the response to .a high salt diet will be discussed within the individual strains. Finally, 
differences between the strains will be discussed. The initial control period included 4 
days on a normal diet of 0. 7% salt after which the diet was increased to 8% salt for 6 
weeks for the experimental animals while the control animals remained at normal salt. 
For ease of understanding, the group of C57 mice on the regular salt diet will be 
called C57-RS, the group of C57 mice on the high salt diet will be called C57-HS, the 
group of eNOS knockout mice on the regular salt diet will be called eNOS-KO-RS and 
the group of eNOS-KO mice on the high salt diet will be referred to as eNOS-KO-HS. 
3.1 Experimental Numbers 
In total, 28 mice were used to conduct statistical analysis. Both the C57-RS and 
C57-HS groups contained 7 mice, whereas the eNOS-KO-RS group contained 8 mice and 
the eNOS-KO-HS group contained 6 mice. Due to a mistake in the recording schedule, 
data for 2 mice from the eNOS-KO-HS group and one mouse from the eNOS-KO-RS 
group were not available for the first and second day of the high salt diet. As well, due to 
a clot at the catheter tip and loss of signal, data for one eNOS-KO-RS mouse is missing 
on the final day of the experiment and data for one C57-RS mouse is missing on the final 
two days of the experiment. The fact that 54 mice started the experiment and only 28 
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completed the full protocol demonstrates the difficulty maintaining a good signal for 8 
weeks of recording. 
3.2 Control Period Hemodynamics 
Control period hemodynamics are summarized in tables 2, 3 and 4. With one 
exception, no differences were observed in the hemodynamic parameters of the regular 
and high salt groups during the control period (table 3). There were no major differences 
in HR, pulse pressure or activity levels between the two strains (table 4) or between the 
experimental groups in each strain (table 2 and 3). 
When the data of the two experimental groups within each strain were combined 
(table 4) significant differences were observed in the 24h MAP, 12h light period and 12h 
dark period MAP, as well as the MAP range over 24h and the daily minimum and 
maximum MAP (table 4). In each case, the values in eNOS-KO mice were greater than 
those of the C57 control mice. 
3.3 Response to a High Salt Diet 
3.3.1 Food and Water Intakes 
Water intake data are summarized in table 5. Water intakes of both C57 
and eNOS knockout mice were significantly increased when fed a high salt diet. eNOS-
KO-HS showed a greater water intake in the experimental period relative to the 
corresponding C57 group. No significant differences were seen in the water intake of the 
C57-RS or the eNOS-KO-RS mice over the course of the experiment. As well, no 
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Table 2: Comparison of control period hemodynamics in the four experimental 
groups. The mean(± SE) for the absolute values of each variable is reported. 
C57 Mice eNOS Mice 
Control Experimental Control Experimental 
Diet (n=7) Diet {n=7) Diet (n=8) Diet (n=6) 
Mean Arterial Pressure (mmHg) 
24h MAP 108 ± 1 105 ± 1 123 ± 2 121 ± 2 
Light Period MAP 100 ± 2 97 ± 1 113 ± 2 113 ± 1 
Dark Period MAP 116 ± 1 112 ± 1 131 ± 3 130 ± 3 
Range of 24h MAP 54± 2 54 ±2 79± 8 71 ± 5 
24h Minimum MAP 83 ± 1 81 ± 1 89 ± 1 90±2 
24h Maximum MAP 137 ± 1 135 ± 1 168 ± 7 161 ± 3 
Heart Rate (bpm) 
24h Heart Rate 578 ± 10 542 ± 11 547 ± 9 571 ± 10 
Light Period Heart Rate 551 ± 15 499 ± 11* 508± 9 531 ± 9 
Dark Period Heart Rate 605 ± 9 585 ± 18 586 ± 11 612 ± 14 
Pulse Pressure (mmHg) 
24h Pulse Pressure 30 ± 1 31 ± 2 33 ± 2 34 ± 2.4 
Light Period Pulse Pressure 29 ± 1 31 ± 2 32 ±2 33±2 
Dark period Pulse Pressure 30 ± 1 31 ± 2 33 ±2 35 ± 3 
Active Time(% time active) 
24h Active Time 37 ± 2 36 ± 3 43 ± 5 40 ± 1.5 
Light Period Active Time 19 ± 2 19 ± 2 19 ± 1 22 ±3 
Dark Period Active Time 56± 3 53±6 54±3 60±2 
Intensity of Activity** 
24h Intensity of Activity 1.2 ± 0.1 1.2 ± 0.0 1.2 ± 0.1 1.2 ± 0.1 
Light Period Intensity of Activity 0.98 ± 0.0 0.96 ± 0.1 0.94 ± 0.0 1.0 ± 0.0 
Dark Period Intensity of Activity 1.24 ± 0.1 1.25 ± 0.1 1.3 ± 0.0 1.3 ± 0.1 
*p<O.OS between diet groups, within strain (see table 3). 
**-Dimensionless (no units) because it represents the mean of log (activity) when 
activity >0. 
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Table 3: P-values for the analysis of variance for the control period hemodynamics 
in C57 and eNOS knockout mice. Statistical analysis was conducted using a general 
linear model analysis of variance to test for differences in the experimental groups within 
the strains of mice during the control period. 
C57-RS C57-HS C57-RS eNOS-KO-RS 
vs. vs. vs. vs. 
C57-HS eNOS-KO-HS eNOS-KO-RS eNOS-KO-HS 
Mean Arterial Pressure 
24h Mean Arterial Pressure 0.4347 <0.0001 <0.0001 0.7840 
Light Period Mean Arterial Pressure 0.5227 <0.0001 <0.0001 0.9877 
Dark Period Mean Arterial Pressure 0.8474 <0.0001 <0.0001 0.9896 
Range of Mean Arterial Pressure 0.5979 0.0732 0.0028 0.9998 
24h Minimum Arterial Pressure 0.2948 0.0837 <0.0001 0.6733 
24h Maximum Arterial Pressure 0.9990 0.0007 0.0002 0.9732 
Heart Rate 
24h Heart Rate 0.0543 0.1686 0.0974 0.2760 
Light Period Heart Rate 0.0080 0.1749 0.0256 0.3990 
Dark Period Heart Rate 0.6462 0.4536 0.6573 0.4590 
Pulse Pressure 
24h Pulse Pressure 0.9162 0.7852 0.6420 0.9600 
Light Period Pulse Pressure 0.8269 0.9505 0.5411 0.9996 
Dark period Pulse Pressure 0.9746 0.5671 0.7582 0.8460 
Active Time 
24h Active Time 0.9882 0.7011 0.6131 0.9809 
Light Period Active Time 1.0000 0.4870 0.9973 0.6010 
Dark Period Active Time 0.9488 0.5668 0.9608 0.5817 
Intensity of Activity 
24h Intensity of Activity 1.0000 0.9586 0.9816 0.9994 
Light Period Intensity of Activity 0.9643 0.7644 0.8356 0.5471 
Dark Period Intensity of Activity 0.9986 0.9877 0.8891 0.9972 
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Table 4: Comparison of control period hemodynamics in C57 and eNOS knockout 
mice. Analysis of variance revealed only one significant difference between control and 
experimental groups during the control period (table 2) so the groups were combined as is 
shown below. 
C57 Mice (n=14) eNOS Micejn=14}_ 
Mean Arterial Pressure (mmHg} 
24h MAP 106 ± 0.7 123 ± 1.3 * 
Light Period MAP 98 ± 1.2 113 ± 1.0 * 
Dark Period MAP 114 ± 0.9 131 ±2.0 * 
Range of MAP 54± 1.2 76 ± 4.5 * 
24h Minimum MAP 82 ± 0.7 89 ± 1.2 * 
24h Maximum MAP 136 ± 0.9 165 ± 4.2 * 
Heart Rate (bpm} 
24h Heart Rate 560 ± 8.6 557 ± 7.2 
Light Period Heart Rate 525 ± 11 518 ± 7 
Dark Period Heart Rate 595 ± 10 597 ± 9 
Pulse Pressure (mmHg} 
24h Pulse Pressure 30 ± 1.0 33 ± 1.5 
Light Period Pulse Pressure 30 ± 1 33 ±2 
Dark period Pulse Pressure 31 ± 1 34 ± 2 
Active Time(% time active) 
24h Active Time 37 ± 1.6 42 ± 2.7 
Light Period Active Time 19 ± 1 20 ± 1 
Dark Period Active Time 55± 3 56± 2 
Intensity of Activity** 
24h Intensity of Activity 1.2 ± 0.0 1.2 ± 0.0 
Light Period Intensity of Activity 0.97 ± 0.0 0.97 ± 0.0 
Dark Period Intensity of Activity 1.2 ± 0.0 1.3 ± 0.0 
*-p<0.05 between groups, unpaired student's T-test. 
** -Dimensionless (no units) because it represents the mean of log (activity) when 
activity >0. 
45 
Table 5: Comparison of daily water intake values in C57 and eNOS knockout mice. 
Average water intakes are reported in glkg body weight/d. Statistical analysis was 
conducted using an analysis of variance general linear model. 
C57 Mice eNOS Knockout Mice 
Control Experimental Control Experimental 
Group Group Group Group 
Control diet 183 ± 15.5 185 ± 24.3 205± 10.0 214 ± 9.0 
6 wk Experimental 
period 160 ± 9.8 540 ± 33.1 * 195 ± 9.4 814 ± 48.9 * 
*-p<0.05 within strain difference between control and experimental period 
-p<0.05 within strain difference between the control and experimental group 
-p<0.05 between strain difference 
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difference was seen in the water intake of the regular and high salt groups during the 
control period. 
Food intake data are summarized in table 6. Within the eNOS-KO strain, food 
consumption w~s significantly (p<O.OOl) greater in the eNOS-KO-HS mice versus the 
eNOS-KO-RS mice in the experimental period. The food intake of the eNOS-KO-HS 
mice was also greater than that of the corresponding C57 group. The food intake of the 
C57-RS, C57-HS and eNOS-KO-RS did not change between the control and 
experimental periods. As well, no difference was observed in the food intake during the 
control period between the control or experimental diet mice in either strain. 
3.3.2 Implantation Data 
Data concerning the age and body weight of animals at the time of telemeter 
implantation are summarized in table 7. The average age of C57 and eNOS knockout 
mice at telemeter implantation was about 14 wks. The average body weight at the time 
of implantation was significantly lower in eNOS knockout mice. This was expected 
because the body weight of knockout mice is generally lower than that of the control 
strain (Van Vliet et al, 2003). 
3.4 Time Course of Responses to Dietary Salt in C57 Mice 
Statistical analysis was conducted using Dunnet's test to determine at what time 
points significant differences in hemodynamic values occurred relative to the last day of 
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Table 6: Comparison of daily food intake values in C57 and eNOS knockout mice. 
Average intakes are reported in g!kg body weight/d. Statistical analysis was conducted 
using an analysis of variance general linear model. 
C57 Mice eNOS Knockout Mice 
Control Experimental Control Experimental 
Group Group Group Group 
Control Diet 148 ± 7.2 141 ± 6.9 152 ± 7.4 159 ± 5.7 
6 wk Experimental 
period 136 ± 6.4 140 ± 7.0 139 ± 4.8 183 ± 11.2 
-p<O.OS within strain difference between the control and experimental group 
-p<O.OS between strain difference 
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Table 7: Implant data for C57 and eNOS knockout mice. 
C57 Mice eNOS Knockout Mice 
Average Implant Age (wks) 13.6 ± 0.5 14.3 ± 0.4 
Implant Age Range (wks) 11-18 13-17 
Average Implant Weight (g) 26.9 ± 0.6 24.4 ± 0.4 * 
Implant Weight Range (g) 24-30 24-27 
*-p<0.05 between strains, Students t-test. 
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the control period. No significant differences were observed within the control period. 
3.4.1 Mean Arterial Pressure 
Mean arterial pressure data is summarized in figures 1, 2, 3 and 4. C57 mice 
experienced a significant rise in 24h MAP when consuming a high salt diet. The salt 
induced rise in BP appeared to follow a two part time course (figure 1). The first part 
consisted of a significant initial transient rise in BP seen immediately following initiation 
of the high salt diet. The second phase consisted of a slow continual rise in BP which 
reached significance at the end of the experiment. C57-RS mice did not exhibit a change 
in MAP from control levels. 
The effect of salt on MAP was observed in both the light and dark phases of the 
day (figure 1). The light phase showed a biphasic response with statistical significance 
seen only at the start of week 1 and during week 6. In the dark phase the increase of 
MAP was more sustained with significance seen during week 1, 3, 4 and 6 on the high 
salt diet. By week 5 on the high salt diet most of the increase in 24h MAP appeared to 
occur during the dark phase of the day (figure 1). A similar tendency was apparent in the 
circadian variation in MAP (figures 2 & 3). 
Although the Dunnett's test did not reveal any significant changes in the range of 
the MAP or the daily minimum or maximum MAP, a tendency was observed for the 
range and the daily maximum to increase initially when the C57 mice were placed on a 
high salt diet (figure 4). 
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Figure 1: The effect of a high salt diet on mean arterial pressure (MAP) in control 
(C57) mice. The experimental high salt diet was started at time 0, indicated by the 
vertical dashed line. The top graph shows the effect of salt on the 24h MAP, the middle 
graph shows the effect on MAP during the 12h light phase of the day and the bottom 
graph shows the effect on MAP during the 12h dark phase of the day. Significant 
differences from the final day of the control period based on Dunnet's test are indicated 
by '*' located above the data point. 
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Figure 2: Comparison of circadian rhythm during the control week and during 
experimental week 5 for control (C57) mice fed the regular salt diet. The mean 
arterial pressures (MAP) shown here are half hour averages over a 24h period. The first 
half of the time scale represents the light period of the day and the second half, to the 
right of the vertical line, represents the dark phase of the day. 
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Figure 3: Comparison of circadian rhythm during the control week and during 
experimental week 5 for control (C57) mice fed the high salt diet. The mean arterial 
pressures (MAP) shown here are half hour averages over a 24h period. The first half of 
the time scale represents the light period of the day and the second half, to the right of the 
vertical line, represents the dark phase of the day. 
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Figure 4: The effect of a high salt diet on the 24h range, minimum and maximum 
mean arterial pressure (MAP) in control (C57) mice. The experimental high salt diet 
was started at time 0, indicated by the vertical dashed line. The top graph shows the 
effect of salt on the 24h range of the MAP, the middle graph shows the effect on the daily 
minimum MAP and the bottom graph shows the effect on the daily maximum MAP. A 
Dunnet' s test indicated no significant differences from the final day of the control period 
were present. 
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3.4.2 Heart Rate 
HR data are summarized in figure 5. In general, the HR tended to decrease over 
the course of the experiment with greater effects tending to be seen in the C57-RS group 
(figure 5). The decrease in 24h HR was significant during weeks 3, 4 and 6 on regular 
salt (figure 5). C57-HS mice showed a tendency towards a small (not significant) 
increase in HR during the first few days on a high salt diet followed by a gradual 
decrease (also not significant) until week 6 (figure 5). This initial tendency for HR to 
increase corresponds with an initial increase in activity at the onset of the high salt diet 
(see below). 
3.4.3 Pulse Pressure 
Pulse pressure data is summarized in figure 6. The pulse pressure of the C57-HS 
mice increased gradually during the course of the experiment (figure 6). A significant 
increase was observed during the final week of the high salt diet. Significant increases in 
pulse pressure were also observed during week 5 and 6 of the high salt diet in the dark 
phase of the day whereas no significant changes were observed in the light phase of the 
day. In C57-RS mice there was a downward trend in pulse pressure but no significant 
changes were seen in either the 24h, light or dark phase data (figure 6). 
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Figure 5: The effect of a high salt diet on the heart rate (HR) in control (C57) mice. 
The experimental high salt diet was started at time 0, indicated by the vertical dashed 
line. The top graph shows the effect of salt on the 24h HR, the middle graph shows the 
effect on HR during the 12h light phase of the day and the bottom graph shows the effect 
on HR during the 12h dark phase of the day. Significant differences from the final day of 
the control period based on Dunnet's test are indicated by'*' located adjacent to the data 
point. 
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Figure 6: The effect of a high salt diet on the pulse pressure in control (C57) mice. 
The experimental high salt diet was started at time 0, indicated by the vertical dashed 
line. The top graph shows the effect of salt on the 24h pulse pressure, the middle graph 
shows the effect on pulse pressure during the 12h light phase of the day and the bottom 
graph shows the effect on pulse pressure during the 12h dark phase of the day. 
Significant differences from the final day of the control period based on Dunnet's test are 
indicated by '*' located above the data point. 
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3.4.4 Activity 
Activity data is summarized in figures 7 and 8. No changes from the control 
values were observed in either the C57-RS or C57-HS mice in the 24hr active time or 24h 
intensity of activity (figures 7 & 8). In the C57-HS mice, active time and the intensity of 
activity tended to increase, similar to the initial increase seen in HR. However, this 
tendency only reached significance in the case of the active time on day 1 of salt 
exposure in the light phase (figure 7). 
3.5 Time Course of Responses to Dietary Salt in eNOS Knockout Mice 
As with the C57 mice, statistical analysis was conducted using Dunnet's test to 
determine at what time points significant differences occurred relative to the last day of 
the control period. No significant differences occurred within the control period. 
3.5.1 Mean Arterial Pressure 
The MAP data is summarized in figures 9, 10, 11 and 12. eNOS knockout 
mice exhibited a significant rise in MAP when consuming a high salt diet (figure 9). The 
24h MAP was significantly increased throughout the entire experimental period and did 
not exhibit the pronounced biphasic time course seen in the C57 mice (figure 1 ). The 
eNOS-KO-RS mice did not show any significant changes in MAP from the control level. 
58 
0 15 
.b 10 
... c:: 0-::;:, (.) .. 5 0 E .5 
.c ol- 0 
-=o 
~ &~ 
-5· N c::-
.2 
(.) 
-
0 
.b 10 .c c:: 
.!2l 0-(.) .. 5 E .5 _. 
0 .... 0 ... -
.c '; 0 
N 01~ 
-5 c:-
~ 
.2 
(.) 
-10 
-15 
0 
15-10 
.::e. .b 10 c:: 
... o-
ftS (.) .. 5 E .5 c ol- 0 
.::o 
.c &~ 
-5 N c::-
~ .2 
-10 (.) 
-15 
-10 
C57 Mice: Active Time I -Q- Regular Salt 
-·-High Salt 
I 
I 
~---:l~=~---~~----~--~~~~-~~~~-~----~-
: -  -~ :2._- :Q:-"" --'1.- :0._ 
I 
I 
I 
-5 () 
-5 0 
5 10 
5 10 
15 20 25 30 35 40 
.... 
-----------lf.-----li--
----41------ ------
-.2.-~ :Q_ 
* 
15 20 25 30 35 40 
Time (Day) 
45 
45 
Figure 7: The effect of a high salt diet on the active time (percent of time spent 
active) in control (C57) mice. The experimental high salt diet was started at time 0, 
indicated by the vertical dashed line. The top graph shows the effect of salt on the 24h 
active time, the middle graph shows the effect on active time during the 12h light phase 
of the day and the bottom graph shows the effect on active time during the 12h dark 
phase of the day. Significant differences from the final day of the control period based 
on Dunnet's test are indicated by'*' located above the data point. 
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Figure 8: The effect of a high salt diet on the intensity of activity in control (C57) 
mice. The experimental high salt diet was started at time 0, indicated by the vertical 
dashed line. The top graph shows the effect of salt on the 24h intensity of activity, the 
middle graph shows the effect on intensity of activity during the 12h light phase of the 
day and the bottom graph shows the effect on intensity of activity during the 12h dark 
phase of the day. A Dunnet's test indicated no significant differences were present. The 
plotted values are dimensionless (have no units) because it represents the intensity of 
activity as the mean of log (activity) when activity >0. 
60 
eNOS knockout Mice: Mean Arterial Pressure 
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Figure 9: The effect of a high salt diet on the mean arterial pressure (MAP) in eNOS 
knockout mice. The experimental high salt diet was started at time 0, indicated by the 
vertical dashed line. The top graph shows the effect of salt on the 24h MAP, the middle 
graph shows t~e effect on MAP during the 12h light phase of the day and the bottom 
graph shows the effect on MAP during the 12h dark phase of the day. Significant 
differences from the final day of the control period based on Dunnet's test are indicated 
by '*' located above the data point. 
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Figure 10: Comparison of circadian rhythm during the control week and during 
experimental week 5 for eNOS knockout mice fed the regular salt diet. The mean 
arterial pressures shown here are half hour averages over a 24h period. The first half of 
the time scale represents the light period of the day and the second half, to the right of the 
vertical line, represents the dark phase of the day. 
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Figure 11: Compariso~ of circadian rhythm during the control week and during 
experimental week 5 for eNOS knockout mice fed the high salt diet. The mean 
arterial pressures shown her~ ~e half hour averages over a 24h period. The first half of 
the time scale represents the light period of the day and the second half, to the right of the 
vertical line, represents the dark phase of the day. 
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Figure 12: The effect of a high salt diet on the 24h range, minimum and maximum 
mean arterial pressure (MAP) in eNOS knockout mice. The experimental high salt 
diet was started at time 0, indicated by the vertical dashed line. The top graph shows the 
effect of salt on the 24h range of the MAP, the middle graph shows the effect on the daily 
minimum MAP and the bottom graph shows the effect on the daily maximum MAP. 
Significant differences from the final day of the control period based on Dunnet's test are 
indicated by'*' located above the data point. 
64 
The high salt diet caused an increase in MAP that was mainly confined to the dark 
phase in the eNOS-KO mice (figure 9). Although a tendency for the MAP to increase 
was seen in the light phase, no significant differences were observed. During the dark 
phase, the increase in MAP was well sustained during the experimental period. A similar 
tendency was apparent in the circadian variation in MAP (figures 10 & 11 ). 
The daily range, minimum and maximum MAP showed a tendency to increase 
that reached significance by the end of the experiment (figure 12). The daily maximum 
MAP appeared to increase considerably more than the daily minimum MAP, thereby 
expanding the 24h range. 
3.5.2 Heart Rate 
HR data is summarized in figure 13. No significant differences were observed in 
the 24h, light or dark HR values in either the control or high salt diet groups. The HR of 
the eNOS-KO-HS mice showed a tendency to decrease below that of the control mice 
(figure 13). This tendency was most pronounced in the case of the data for the 24h and 
light period. 
3.5.3 Pulse Pressure 
The pulse pressure data is summarized in figure 14. In general, the pulse pressure 
of eNOS mice on the high salt diet showed a tendency to gradually increase over the 
course of the experiment but no significant differences were observed (figure 14). This is 
similar to the effect seen in C57-HS mice. However, the eNOS-KO-RS mice did not 
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Figure 13: The effect of a high salt diet on the heart rate (HR) in eNOS knockout 
mice. The experimental high salt diet was started at time 0, indicated by the vertical 
dashed line. The top graph shows the effect of salt on the 24h HR, the middle graph 
shows the effect on HR during the 12h light phase of the day and the bottom graph shows 
the effect on HR during the 12h dark phase of the day. A Dunnet's test indicated no 
significant differences from the fmal day of the control period were present. 
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Figure 14: The effect of a high salt diet on the pulse pressure in eNOS knockout 
mice. The experimental high salt diet was started at time 0, indicated by the vertical 
dashed line. The top graph shows the effect of salt on the 24h pulse pressure, the middle 
graph shows the effect on pulse pressure during the 12h light phase of the day and the 
bottom graph shows the effect on pulse pressure during the 12h dark phase of the day. A 
Dunnet' s test indicated no significant differences from the final day of the control period 
were present. 
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show a similar downward trend in pulse pressure as was seen in the case of C57-RS mice 
(figure 14). 
3.5.4 Activity 
Activity data is summarized in figure 15 and 16. The active time showed a 
tendency to increase when the mice were placed on a high salt diet (figure 15). 
However, the increase was only significant on day 1 of the high salt group in the light 
phase. No significant changes were observed in the control group. 
In general, no significant changes or specific trends were evident in the intensity 
of activity during the 24hr light or dark phases (figure 16). 
3.6 Responses to Dietary Salt: Comparison between C57 and eNOS Knockout Mice 
Statistical analysis was conducted using ANOVA and Tukey's test to determine 
differences between the four experimental groups: C57-RS, C57-HS, eNOS-KO-RS and 
eNOS-KO-HS. When comparing the C57 mice to the eNOS knockout mice, the response 
to salt was broken into four phases (control, early, middle and late) in order to ensure that 
the power of the statistical test was not diminished. These divisions were arbitrarily 
assigned to help simplify the interpretation of the statistical comparisons. 
Analysis of variance showed that the effects of strain, diet and time were all 
highly significant in all variables except intensity of activity (tables 8 & 9). Statistical 
outcomes between the interaction of strain, day and time varied between variables (tables 
8 & 9). 
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Figure 15: The effect of a high salt diet on the active time (percent of time spent 
active) in eNOS knockout mice. The experimental high salt diet was started at time 0, 
indicated by the vertical dashed line. The top graph shows the effect of salt on the 24h 
active time, the middle graph shows the effect on active time during the 12h light phase 
of the day and the bottom graph shows the effect on active time during the 12h dark 
phase of the day. Significant differences from the final day of the control period based 
on Dunnet's test are indicated by'*' located above the data point. 
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eNOS knockout Mice: Intensity of Activity 
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Figure 16: The effect of a high salt diet on the intensity of activity in eNOS knockout 
mice. The experimental high salt diet was started at time 0, indicated by the vertical 
dashed line. The top graph shows the effect of salt on the 24h intensity of activity, the 
middle graph shows the effect on intensity of activity during the 12h light phase of the 
day and the bottom graph shows the effect on intensity of activity during the 12h dark 
phase of the day. A Dunnet' s test indicated no significant differences were present. The 
plotted values are dimensionless (have no units) because it represents the intensity of 
activity as the mean of log (activity) when activity >0. 
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Table 8: P-values for the analysis of variance of hemodynamic data in the four 
experimental groups. Statistical analysis using analysis of variance compared strain, 
ct· t r d th · t r b tw th · t 1 · bl 1e, tme an em erac ton e een ese pom s across severa vana es. 
Mean Arterial Pressure 24h Light Period Dark Period 
Strain <0.0001 <0.0001 <0.0001 
Diet <0.0001 <0.0001 <0.0001 
Time <0.0001 <0.0001 <0.0001 
Strain*Diet <0.0001 <0.0001 <0.0001 
Strain*Time <0.0001 0.023 <0.0001 
Diet*Time <0.0001 0.012 <0.0001 
Strain*Diet*Time <0.001 0.078 <0.01 
Heart Rate 
Strain <0.0001 <0.0001 0.004 
Diet 0.829 0.001 0.003 
Time <0.0001 <0.0001 0.003 
Strain*Diet <0.0001 <0.0001 0.013 
Strain*Time 0.004 0.005 0.029 
Diet*Time 0.075 0.026 0.023 
Strain*Diet*Time 0.024 0.012 0.15 
Pulse Pressure 
Strain <0.0001 0.017 <0.0001 
Diet 0.001 0.075 <0.0001 
Time 0.001 0.108 <0.0001 
Strain*Diet 0.396 0.153 0.844 
Strain*Time 0.076 0.245 0.015 
Diet*Time 0.002 0.043 <0.0001 
Strain*Diet*Time 0.799 0.642 0.879 
Active Time 
Strain 0.001 0.705 <0.0001 
Diet <0.0001 0.536 <0.0001 
Time <0.0001 <0.0001 <0.0001 
Strain*Diet 0.734 0.015 0.372 
Strain*Time 0.041 0.031 0.051 
Diet*Time <0.0001 0.002 <0.0001 
Strain*Diet*Time 0.779 0.413 0.556 
Intensity of Activity 
Strain 0.333 0.575 0.206 
Diet <0.0001 0.256 0.001 
Time <0.0001 0.013 <0.0001 
Strain*Diet 0.084 0.015 0.121 
Strain*Time 0.475 0.945 0.398 
Diet*Time 0.121 0.077 0.224 
Strain*Diet*Time 0.09 0.112 0.161 
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Table 9: P-values for the analysis of variance for the daily range, minimum and 
maximum MAP for the four experimental groups. Statistical analysis of variance 
compared strain, diet, time and the interaction between these points across range of MAP, 
daily minimum MAP and daily maximum MAP. 
Comparison Range of MAP 24h Daily Minimum 24h Daily Maximum 
Strain 0.573 <0.0001 <0.0001 
Diet <0.0001 0.908 <0.0001 
Time 0.014 <0.0001 <0.0001 
Strain*Diet 0.06 0.001 <0.0001 
Strain*Time 0.578 <0.0001 0.034 
Diet*Time <0.0001 0.556 <0.0001 
Strain*Diet*Time 0.003 0.091 <0.0001 
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3.6.1 Mean Arterial Pressure 
Between group comparisons for MAP are summarized in figures 17, 18, 19, 20, 
21 and 22 and in tables 10, 11, 12, 13, 14 and 15. In both C57 and eNOS knockout mice, 
MAP was significantly increased by the high salt diet (figures 17, 18 & 19 and tables 10, 
11 & 12). The response of eNOS knockout mice was significantly greater than that of 
C57 mice (tables 10, 11 & 12). eNOS knockout mice showed a sustained increase in 
MAP whereas the response of the C57 mice was mostly transient. 
In general, the MAP response to high salt appeared to be most pronounced during 
the dark phase of the day (figure 19). In C57 mice, the MAP response to high salt was 
largely confined to the dark phase of the day. Although the most predominant effect of 
the high salt diet was also observed in the dark phase of the day in eNOS-KO, statistical 
differences were also observed during the light phase of the day (figures 18 & 19 and 
tables 11 & 12). 
During the control period, the eNOS-KO mice had significantly higher absolute 
values for the range, daily minimum and maximum (table 2 & 4). The eNOS-KO-HS 
mice showed a salt-induced increase in the daily range and minimum by the end of the 
experiment and a sustained increase in the daily maximum throughout the entire 
experimental period (figures 20, 21 & 22; tables 13, 14 & 15). In contrast, the C57-HS 
mice showed an initial increase in the daily range and maximum and no significant 
change in the daily minimum (figures 20, 21 & 22; tables 13, 14 & 15). 
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Figure 17: Comparison of the effect of a high salt diet on 24h mean arterial pressure 
in C57 and eNOS knockout mice. The experimental diet is started at time 0, indicated 
by the solid vertical line. The experimental period is broken into four phases (control, 
early, middle and late) to ensure the power of the statistical comparisons were not 
diminished. The statistical results are summarized in table 10. 
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Table 10: The effect of a high salt diet on 24h mean arterial pressure in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups {Tukey's test). The response is broken down Into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 <0.0001 <0.0001 <0.0001 
eNOS-KO-HS vs. C57 -HS 1.0000 <0.0001 <0.0001 <0.0001 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9960 0.8717 0.3380 
C57-RS vs. C57-HS 1.0000 <0.0001 0.8390 0.2420 
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Figure 18: Comparison of the effect of a high salt diet on 12h light period mean 
arterial pressure in C57 and eNOS knockout mice. The experimental diet is started at 
time 0, indicated by the solid vertical line. The experimental period is broken into four 
phases (control, early, middle and late) to ensure the power of the statistical comparisons 
were not diminished. The statistical results are summarized in table 11. 
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Table 11: The effect of a high salt diet on 12h light period mean arterial pressure in 
C57 and eNOS knockout mice. This table provides p-values for the statistical 
comparisons between groups (Tukey's test). The response is broken down into four 
phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.0001 0.9819 0.0008 
eNOS-KO-HS vs. C57-HS 1.0000 0.0008 0.1169 0.0004 
eNOS-KO-RS vs. C57 -RS 1.0000 1.0000 1.0000 1.0000 
C57-RS vs. C57-HS 1.0000 0.9980 1.0000 1.0000 
77 
Mean Arterial Pressure: Dark Period (mmHg) -0-C57-RS 
-··-· C57-HS 
-0- eNOS-KO-RS 
C,ontrol Early 
24 
Q) 22 
~ 20 
0 18 
... 16 ... c: 
0 14 (.) 
Q) 12 
-'= 10 ... 
I 
Middle ! Late 
ll i T _,{'' ',, I I 
i I ..... -- ~ ', -----
i ,.,"' ! 
i " " ! 
---- I ! i 
I ' 
' I I ' 
' I I ' 
, I 
I • 
- ··- · eNOS-KO-HS 
E 8 0 
... 6 
-Q) 4 C) 
' I 
! -·--~-"""'..!. -- • 
c: 2 ns 
-'= 0 (.) 
-2 
-4 
-6 
-7 0 7 14 21 28 35 42 
Time (Days on Experimental Diet) 
Figure 19: Comparison of the effect of a high salt diet on 12h dark period mean 
arterial pressure in C57 and eNOS knockout mice. The experimental diet is started at 
time 0, indicated by the solid vertical line. The experimental period is broken into four 
phases (control, early, middle and late) to ensure the power of the statistical comparisons 
were not diminished. The statistical results are summarized in table 12. 
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Table 12: The effect of a high salt diet on 12h dark period mean arterial pressure in 
C57 and eNOS knockout mice. This table provides p-values for the statistical 
comparisons between groups (Tukey's test). The response is broken down into four 
phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 <0.0001 <0.0001 <0.0001 
eNOS-KO-HS vs. C57-HS 1.0000 <0.0001 <0.0001 <0.0001 
eNOS-KO-RS vs. C57-RS 1.0000 0.1510 0.8230 0.3000 
C57-RS vs. C57-HS 1.0000 <0.0001 0.4000 0.0060 
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Figure 20: Comparison of the effect of a high salt diet on 24h range of mean arterial 
pressure in C57 and eNOS knockout mice. The experimental diet is started at time 0, 
indicated by the solid vertical line. The experimental period is broken into four phases 
(control, early, middle and late) to ensure the power of the statistical comparisons were 
not diminished. The statistical results are summarized in table 13. 
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Table 13: The effect of a high salt diet on 24h range of mean arterial pressure in 
C57 and eNOS knockout mice. This table provides p-values for the statistical 
comparisons between groups (Tukey's test). The response is broken down into four 
phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.9620 0.0111 <0.0001 
eNOS-KO-HS vs. C57 -HS 1.0000 0.5502 0.9999 0.6681 
eNOS-KO-RS vs. C57 -RS 1.0000 1.0000 0.9995 0.7136 
C57 -RS vs. C57 -HS 1.0000 0.0032 0.9058 0.9883 
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Figure 21: Comparison of the effect of a high salt diet on daily minimum mean 
arterial pressure in C57 and eNOS knockout mice. The experimental diet is started at 
time 0, indicated by the solid vertical line. The experimental period is broken into four 
phases (control, early, middle and late) to ensure the power of the statistical comparisons 
were not diminished. The statistical results are summarized in table 14. 
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Table 14: The effect of a high salt diet on daily minimum mean arterial pressure in 
C57 and eNOS knockout mice. This table provides p-values for the statistical 
comparisons between groups (Tukey' s test). The response is broken down into four 
phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.2339 1.0000 0.662 
eNOS-KO-HS vs. C57 -HS 1.0000 0.0001 0.0026 <0.0001 
eNOS-KO-RS vs. C57-RS 1.0000 1.0000 0.6594 0.0094 
C57-RS vs. C57-HS 1.0000 0.3206 0.9367 1.0000 
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Figure 22: Comparison of the effect of a high salt diet on daily maximum mean 
arterial pressure in C57 and eNOS knockout mice. The experimental diet is started at 
time 0, indicated by the solid vertical line. The experimental period is broken into four 
phases (control, early, middle and late) to ensure the power of the statistical comparisons 
were not diminished. The statistical results are summarized in table 15. 
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Table 15: The effect of a high salt diet on daily maximum mean arterial pressure in 
C57 and eNOS knockout mice. This table provides p-values for the statistical 
comparisons between groups (Tukey's test). The response is broken down into four 
phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 <0.0001 <0.0001 <0.0001 
eNOS-KO-HS vs. C57-HS 1.0000 0.0121 0.0646 <0.0001 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9434 1.0000 0.9283 
C57-RS vs. C57-HS 1.0000 <0.0001 0.6918 0.7940 
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3.6.2 Heart Rate 
The HR data is summarized in figures 23, 24 and 25 and in tables 16, 17 and 18. 
In C57 mice, a high salt diet caused a tendency for the HR to increase above that of the 
control group but only reached significance during the early phase of the dark period 
(figures 23, 24 & 25 and tables 16, 17 & 18). A high salt diet in eNOS knockout mice 
caused a tendency for the HR to decrease from that of the control group, reaching 
significance in the late phase of the 24h and the light period (tables 16, 17 & 18). In 
general, salt-induced changes in HR were modest relative to the high absolute values of 
HR in mice (table 2). 
3. 6.3 Pulse Pressure 
The pulse pressure data is summarized in figures 26, 27 and 28 and in tables 19, 
20 and 21. In both C57 and eNOS knockout mice, pulse pressure tended to increase on 
the high salt diet (figure 26). In the C57 mice, the change in pulse pressure reached 
significance in the late phase of both the 24h and the dark periods (figures 26 & 28 and 
tables 19 & 21 ). The eNOS knockout mice only exhibited significant differences in the 
late phase of the dark period (table 21 ). Overall, the pulse pressure response of the two 
strains of mice was not significantly different (tables 19, 20 & 21). 
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Figure 23: Comparison of the effect of a high salt diet on 24h heart rate in C57 and 
eNOS knockout mice. The experimental diet is started at time 0, indicated by the solid 
vertical line. The experimental period is broken into four phases (control, early, middle 
and late) to ensure the power of the statistical comparisons were not diminished. The 
statistical results are summarized in table 16. 
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Table 16: The effect of a high salt diet on 24h heart rate in C57 and eNOS knockout 
mice. This table provides p-values for the statistical comparisons between groups 
(Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 1.0000 0.0028 
eNOS-KO-HS vs. C57-HS 1.0000 0.9962 0.9970 <0.0001 
eNOS-KO-RS vs. C57-RS 1.0000 0.6045 0.0325 0.0001 
C57-RS vs. C57-HS 1.0000 0.0960 0.9990 0.9797 
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Figure 24: Comparison of the effect of a high salt diet on 12h light period heart rate 
in C57 and eNOS knockout mice. The experimental diet is started at time 0, indicated 
by the solid vertical line. The experimental period is broken into four phases (control, 
early, middle and late) to ensure the power of the statistical comparisons were not 
diminished. The statistical results are summarized in table 17. 
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Table 17: The effect of a high salt diet on 12h light period heart rate in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.6184 0.3945 <0.0001 
eNOS-KO-HS vs. C57 -HS 1.0000 1.0000 0.9990 1.0000 
eNOS-KO-RS vs. C57 -RS 1.0000 0.4022 0.0065 <0.0001 
C57-RS vs. C57-HS 1.0000 0.9998 1.0000 1.0000 
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Figure 25: Comparison of the effect of a high salt diet on 12h dark period heart rate 
in C57 and eNOS knockout mice. The experimental diet is started at time 0, indicated 
by the solid vertical line. The experimental period is broken into four phases (control, 
early, middle and late) to ensure the power of the statistical comparisons were not 
diminished. The statistical results are summarized in table 18. 
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Table 18: The effect of a high salt diet on 12h dark period heart rate in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.9811 0.9994 0.9241 
eNOS-KO-HS vs. C57 -HS 1.0000 0.9830 0.9568 1.0000 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9834 0.6059 0.0195 
C57-RS vs. C57-HS 1.0000 0.0004 0.9644 0.6447 
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Figure 26: Comparison of the effect of a high salt diet on 24h pulse pressure in C57 
and eNOS knockout mice. The experimental diet is started at time 0, indicated by the 
solid vertical line. The experimental period is broken into four phases (control, early, 
middle and late) to ensure the power of the statistical comparisons were not diminished. 
The statistical results are summarized in table 19. 
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Table 19: The effect of a high salt diet on 24h pulse pressure in C57 and eNOS 
knockout mice. This table provides p-values for the statistical comparisons between 
groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 1.0000 0.1179 
eNOS-KO-HS vs. C57 -HS 1.0000 0.9990 0.9990 0.9603 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9990 0.3287 0.6726 
C57-RS vs. C57-HS 1.0000 1.0000 0.9943 0.0247 
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Figure 27: Comparison of the effect of a high salt diet on 12h light period pulse 
pressure in C57 and eNOS knockout mice. The experimental diet is started at time 0, 
indicated by the solid vertical line. The experimental period is broken into four phases 
(control, early, middle and late) to ensure the power of the statistical comparisons were 
not diminished. The statistical results are summarized in table 20. 
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Table 20: The effect of a high salt diet on 12h light period pulse pressure in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 1.0000 0.9672 
eNOS-KO-HS vs. C57 -HS 1.0000 1.0000 1.0000 1.0000 
eNOS-KO-RS vs. C57-RS 1.0000 1.0000 0.5450 0.7736 
C57-RS vs. C57-HS 1.0000 1.0000 0.9980 0.2139 
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Figure 28: Comparison of the effect of a high salt diet on 12h dark period pulse 
pressure in C57 and eNOS knockout mice. The experimental diet is started at time 0, 
indicated by the solid vertical line. The experimental period is broken into four phases 
(control, early, middle and late) to ensure the power of the statistical comparisons were 
not diminished. The statistical results are summarized in table 21. 
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Table 21: The effect of a high salt diet on 12h dark period pulse pressure in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey' s test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.9630 1.0000 0.0004 
eNOS-KO-HS vs. C57-HS 1.0000 0.9350 0.9304 0.4180 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9903 0.1963 0.6091 
C57-RS vs. C57-HS 1.0000 0.9979 0.9850 0.0018 
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3.6.4 Active Time 
The active time data is summarized in figures 29, 30 and 31 and tables 22, 23 and 
24. In both the . C57 and eNOS knockout mice, the active time was initially statistically 
increased when the mice were placed on the high salt diet (figures 29, 30 & 31). In 
general, the change in active time in response to a high dietary salt intake was most 
pronounced during the dark phase of the day (figure 31; tables 22, 23 & 24). In the 
eNOS-KO-HS mice, the increase in active time seen in the dark phase was sustained 
throughout the experiment (figure 31). However, the C57-HS mice only showed a 
significant increase in the active time in the dark period during the early phase and late 
phase (tables 22, 23 & 24). 
3.6.5 Intensity of Activity 
The intensity of activity data is summarized in figures 32, 33 and 34 and in tables 
25, 26 and 27. C57-HS mice showed a greater intensity of activity during the early phase 
when placed on a high salt diet (tables 25, 26 & 27). C57-HS mice, unlike the eNOS-
KO-HS mice, had an initial increase in the level of activity in the 24h, light and dark 
periods of the day (figures 32, 33 & 34). No significant differences were seen in the 
intensity of active in the eNOS knockout mice (tables 25, 26 & 27). 
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Figure 29: Comparison of the effect of a high salt diet on 24h active time (percent of 
time spent active) in C57 and eNOS knockout mice. The experimental diet is started at 
time 0, indicated by the solid vertical line. The experimental period is broken into four 
phases (control, early, middle and late) to ensure the power of the statistical comparisons 
were not diminished. The statistical results are summarized in table 22. 
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Table 22: The effect of a high salt diet on 24h active time in C57 and eNOS 
knockout mice. This table provides p-values for the statistical comparisons between 
groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 <0.0001 0.2209 0.8339 
eNOS-KO-HS vs. C57-HS 1.0000 0.5360 0.8017 1.0000 
eNOS-KO-RS vs. C57-RS 1.0000 0.1106 0.9990 0.9948 
C57 -RS vs. C57 -HS 1.0000 <0.0001 0.9419 0.3939 
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Figure 30: Comparison of the effect of a high salt diet on 12h light period active time 
(percent of time spent active) in C57 and eNOS knockout mice. The experimental 
diet is started at time 0, indicated by the solid vertical line. The experimental period is 
broken into four phases (control, early, middle and late) to ensure the power of the 
statistical comparisons were not diminished. The statistical results are summarized in 
table 23. 
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Table 23: The effect of a high salt diet on 12h light period active time in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 0.9511 0.5131 
eNOS-KO-HS vs. C57-HS 1.0000 1.0000 0.9990 0.9207 
eNOS-KO-RS vs. C57-RS 1.0000 0.0032 1.0000 1.0000 
C57 -RS vs. C57 -HS 1.0000 0.0027 1.0000 1.0000 
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Figure 31: Comparison of the effect of a high salt diet on 12h dark period active 
time (percent of time spent active) in C57 and eNOS knockout mice. The 
experimental diet is started at time 0, indicated by the solid vertical line. The 
experimental period is broken into four phases (control, early, middle and late) to ensure 
the power of the statistical comparisons were not diminished. The statistical results are 
summarized in table 24. 
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Table 24: The effect of a high salt diet on 12h dark period active time in C57 and 
eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups {Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 0.0010 0.0039 0.0146 
eNOS-KO-HS vs. C57 -HS 1.0000 0.7120 0.1843 0.9163 
eNOS-KO-RS vs. C57 -RS 1.0000 0.1805 0.9990 0.9813 
C57-RS vs. C57-HS 1.0000 0.0001 0.7344 0.0440 
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Figure 32: Comparison of the effect of a high salt diet on 24h intensity of activity in 
C57 and eNOS knockout mice. The experimental diet is started at time 0, indicated by 
the solid vertical line. The experimental period is broken into four phases (control, early, 
middle and late) to ensure the power of the statistical comparisons were not diminished. 
The plotted values in this graph are dimensionless (no units) because it represents the 
intensity of activity as the mean of log (activity) when activity >0. The statistical results 
are summarized in table 25. 
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Table 25: The effect of a high salt diet on 24h intensity of activity in C57 and eNOS 
knockout mice. This table provides p-values for the statistical comparisons between 
groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 0.9979 0.9986 
eNOS-KO-HS vs. C57 -HS 1.0000 0.0362 1.0000 0.9990 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9948 1.0000 1.0000 
C57-RS vs. C57-HS 1.0000 0.0001 0.8140 0.9892 
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Figure 33: Comparison of the effect of a high salt diet on 12h light period intensity 
of activity in C57 and eNOS knockout mice. The experimental diet is started at time 0, 
indicated by the solid vertical line. The experimental period is broken into four phases 
(control, early, middle and late) to ensure the power of the statistical comparisons were 
not diminished. The plotted values in this graph are dimensionless (no units) because it 
represents the intensity of activity as the mean of log (activity) when activity >0. The 
statistical results are summarized in table 26. 
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Table 26: The effect of a high salt diet on 12h light period intensity of activity in C57 
and eNOS knockout mice. This table provides p-values for the statistical comparisons 
between groups (Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 1.0000 0.9983 
eNOS-KO-HS vs. C57 -HS 1.0000 0.4717 1.0000 1.0000 
eNOS-KO-RS vs. C57-RS 1.0000 0.2869 0.9990 0.9987 
C57-RS vs. C57-HS 1.0000 0.0002 0.9910 1.0000 
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Figure 34: Comparison of the effect of a high salt diet on 12h dark period intensity 
of activity in C57 and eNOS knockout mice. The experimental diet is started at time 0, 
indicated by the solid vertical line. The experimental period is broken into four phases 
(control, early, middle and late) to ensure the power of the statistical comparisons were 
not diminished. The plotted values in this graph are dimensionless (no units) because it 
represents the intensity of activity as the mean of log (activity) when activity >0. The 
statistical results are summarized in table 27. 
110 
Table 27: The effect of salt on 12h dark period intensity of activity in C57 and eNOS 
knockout mice. This table provides p-values for the statistical comparisons between 
groups {Tukey's test). The response is broken down into four phases. 
Control Early Middle Late 
Comparison Week Week 1 Week 2-3 Week 4-6 
eNOS-KO-RS vs. eNOS-KO-HS 1.0000 1.0000 0.9993 0.9996 
eNOS-KO-HS vs. C57 -HS 1.0000 0.1308 1.0000 0.9939 
eNOS-KO-RS vs. C57 -RS 1.0000 0.9976 1.0000 0.9981 
C57-RS vs. C57-HS 1.0000 0.0015 0.9040 0.9958 
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3.7 Mean Arterial Pressure Vs Activity: C57 and eNOS knockout mice. 
In order to clarify the cause of the salt-induced increase in the MAP, analysis was 
conducted to look at the influence of changes in activity on the MAP. To gain a greater 
understanding of the cause of the increase in MAP, we examined 1) the level of activity 
(see previous sections), 2) the mean MAP level when active (MAP ACTIVE) and 3) the 
mean MAP level when inactive (MAPINACTIVE). Table 28 shows the mean changes in 
MAP ACTIVE and MAP INACTIVE during week 1 and week 5 relative to the control period. 
Overall, both C57 and eNOS knockout mice showed an increase in MAP ACTIVE 
when consuming a high salt diet (table 28). During the first and fifth week of salt 
exposure, the C57-HS mice only exhibited a significant increase in MAP ACTIVE in the 24h 
and light period whereas the eNOS-KO-HS mice showed a significant increase in the 
24h, light and dark periods. The eNOS-KO-HS mice also had an increase in 
MAP INACTIVE in the dark period of week 1 and in the 24h, light and dark periods of week 
5. No significant differences were exhibited in the MAPINACTIVE of the C57 mice. No 
significant differences were observed in C57-RS or eNOS-KO-RS mice in either week 1 
or 5. The elevation of the MAP ACTIVE suggests that not all the MAP increases seen with 
the high salt diet can be explained by the coinciding increases in activity. 
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Table 28: Comparison between mean arterial pressure (MAP) during periods of 
activity and inactivity in C57 and eNOS knockout mice. This table shows the effect of 
a control or high salt diet on the change in MAP from control values in periods of activity 
and inactivity during the 24h, light and dark periods. Data is presented for weeks 1 and 5 
of the experimental diet. 
24h MAP 12h Light MAP 12h Dark MAP 
Week 1 Act=O Act>O Act=O Act>O Act=O Act>O 
Control 0 ±1.0 -0.7 ±0.8 0.5 ±1.2 1.4±1.0 -1.1 ±0.96 -1.3 ±0.9 
C57 Salt 2.3 ±1.1 6.6 ±0.9 * 2.1 ±1.0 6.0 ±1.3 * 2.5 ±1.1 7.0 ±0.9 
Control -0.2 ± 1.1 -0.8 ±2.2 -0.4 ±1.0 1.0 ±1.5 0.4 ±1.7 -1.2 ±3.0 
eNOS Salt 4.8 ±1.3 11.4 ±0.6 * 3.4 ±1.7 7.4 ±2.7 * 12.2 ±4.6 * 13±0.9* 
WeekS 
Control 3.1 ±1.9 0.9 ±1.6 2.9 ±1.3 2.5 ±1.5 1.0 ±2.5 0.2 ±1.4 
C57 Salt 2.7 ±0.9 6.3 ±1.2 * 1.5 ±1.0 6.5 ±1.0 * 3.8 ±1.6 6.4 ±1.5 
Control 4.6 ±1.8 0 ±2.7 3 ±1.3 3.2 ±1.0 5.4 ±3.4 -0.6 ±3.4 
eNOS Salt 11 ±3.3 * 17.3 ±4.1 * 6.8 ±3.3 * 11 ±5.4 * 18±3.3* 19 ±4.3 * 
*-p<0.05, stgmficant difference from control period values (Dunnet's test). 
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Chapter 4: Discussion and Conclusion 
A main objective of this study was to investigate the effect of a high salt diet on 
the MAP, HR and activity levels in eNOS knockout mice. A second objective was to 
describe the effect of a high salt diet on hemodynamic values in C57 mice. A final 
objective was to describe differences in basal MAP in eNOS-KO and C57 control mice. 
Our data show that eNOS knockout mice have a heightened salt sensitivity compared to 
the control C57 mice although the C57 mice display a slight degree of salt sensitivity. 
eNOS knockout mice also have a higher basal MAP when compared to C57 mice. 
Relative to the observed changes in MAP and activity levels, changes in the other 
measured variables were less dramatic. The high salt diet had only a slight effect on the 
HR and pulse pressure. Salt-induced changes in HR were limited relative to the high 
absolute values of HR in mice. The C57-HS mice experienced a slight (not significant) 
increase in HR when the high salt diet was initially started whereas the eNOS-KO-HS 
mice exhibited a slight (not significant) decrease in HR at the onset of the high salt diet. 
In both C57 and eNOS-KO mice, pulse pressure exhibited a progressive increase on the 
high salt diet, reaching significance by the end of the experiment. It is possible that with 
a longer experimental protocol more dramatic changes might have been observed in the 
pulse pressure. 
4.1 Salt Sensitivity in C57 Mice 
The C57 mice exhibited a significant increase in MAP in response to the high salt 
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diet during the 6 weeks of exposure. Our results suggest that C57 mice are moderately 
salt sensitive. The maximum increase observed in the average 24h MAP was 
approximately 6 mmHg above control values. This extent of increase was observed 
during both the initial transient response to the high salt diet and also at the end of the 
progressive MAP increase seen in the last 3 weeks of the experiment. The modest extent 
of salt-induced changes in MAP in the C57 group (a.k.a. not entirely resistant to changes 
induced by high salt) suggests that they are an appropriate background strain with which 
to investigate the salt sensitivity caused by a knocked-out gene. If the C57 mice were 
highly salt resistant then it would be less likely that a knockout strain made with their 
genetic background would show salt-induced changes in BP even if the deleted gene 
played a role in controlling salt sensitivity. In other words, a highly salt resistant genetic 
background would have the potential to mask an effect of a gene on salt sensitivity. At 
the same time, the modest level of salt sensitivity of C57 mice would not make them an 
appropriate choice to investigate experimental treatments for salt sensitive hypertension. 
Because the salt-induced increases in MAP were only 6 mmHg above control levels, 
investigations of the effect of experimental treatments for salt sensitivity would need to 
be able to resolve changes in BP of only a few mmHg. 
The salt induced increase in MAP appeared to have a two phase time course. Van 
Vliet et al (2005) suggested that there are two distinct phases of salt sensitivity in Dahl 
salt sensitive rats. Although the mechanisms behind each are unknown, the two phases 
appear to have a different genetic basis (Van Vliet et al, 2005). The initial increase in 
MAP in our C57 mice may be due to volume loading (Manning et al, 1979; Douglas et al, 
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1964). The subsequent decrease of MAP after approximately one week of salt exposure 
to almost normal levels suggests that the body adapts to the elevated salt and water 
intake. It is unclear exactly what physiological mechanism is responsible for returning 
the MAP back to normal levels. Osborn and Hornfeldt (1998) showed a similar decrease 
in MAP values in SD rats. When fed a high salt diet (4% NaCl for 3 weeks and then 8% 
NaCl for 3 weeks), an initial increase in MAP was gradually reduced to near normal 
levels after 3 weeks. In contrast, the return of MAP to normal levels did not occur in 
baroreceptor denervated rats (Osborn & Hornfeldt, 1998). This suggests that the 
baroreceptors are important in the regulation of MAP in the presence of a high salt diet. 
Because mice have a faster life cycle and metabolism than rats, it is plausible that such an 
effect of the baroreceptors may be evident by the end of the first week of exposure to 
high salt. 
The second phase of the MAP response to high salt was a gradual and progressive 
increase in BP. Although the MAP observed in our C57 mice rose over the course of the 
experiment, the increase was modest but may have progressed further if the mice 
continued consuming a high salt diet. In Dahl salt sensitive rats this slow and progressive 
rise in BP appears to be largely irreversible 01 an Vliet, unpublished data). Long term 
changes such as remodeling of the arteries, kidney damage and re-setting of the renal 
function curve may all contribute to the slow rise in BP (Lilly, 1998). 
Previous studies have also suggested that C57 mice display a slight degree of salt 
sensitivity (Gros et al, 2002; Sugiyama et al, 2001; Carlson & Wyss, 2000). Carlson and 
Wyss (2000) examined the MAP in female C57 mice (n= 5, age unspecified) using 
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telemeters to monitor BP. The mice were originally fed a regular salt (0.6% NaCl) diet 
and then switched to a high salt (8% NaCl) diet. After one week on the high salt diet, 
telemeter recordings of MAP were conducted for a period of 4 days (Carlson & Wyss, 
2000). In the p~esent investigation, the male C57 mice experienced an increase of MAP 
of about 6%. Similarly, Carlson and Wyss (2000) found an increase of about 8%. Data 
from the latter study supports the idea that C57 mice are slightly salt sensitive but does 
not provide any concrete information regarding the time course of the salt induced 
augmentation of MAP. In our study the major increase in MAP occurred in the first 
week of salt exposure, whereas Carlson and Wyss (2000) did not begin to monitor MAP 
until 8 days after the mice were placed on the high salt diet. Carlson and Wyss (2000) 
found a significant increase in MAP during days 8-11 on high salt. In contrast, we found 
significant elevations in MAP on days 1-4 and at week 6 on high salt while no major 
changes were observed from day 5 to week 5. The difference in the gender of the mice 
may have contributed to these differences in results. Male mice appear to show a higher 
predisposition to salt sensitive hypertension (Gros et al, 2002). Gros et al (2002) 
demonstrated that 8 week old C57 male mice experienced a significant increase in 
systolic BP after 3 weeks on a high salt (8% NaCl) diet which was associated with a 
major loss of myogenic tone. In contrast, the equivalent female mice did not show an 
increase in systolic BP nor a decrease in myogenic tone after 7 weeks on the high salt diet 
(Gros et al, 2002). 
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Gros et al (2002) used the tail-cuff method to measure BP in order to determine 
the effect of either a normal (n=5) or 8% salt (n=5) diet on BP in male C57 mice (8 
weeks of age). At week 3 of salt exposure, the mice on the high salt diet showed an 
average 18% increase in MAP (Gros et al, 2002). Sugiyama et al (2001) also examined 
the effect of salt on the MAP in male C57 mice (n=8). The latter study also used the tail 
cuff method for the measurements of MAP in C57 mice, 8 ± 1 week of age, given high 
salt water (1% NaCl) for 2 weeks. A significant increase of 14o/o in MAP at the end of 
the 2 week exposure to the high salt water was reported (Sugiyama et al, 2001). One 
reason for the differences in the results of the above studies and those of the present study 
may have been due to the methods used to measure BP (tail cuff compression versus 
telemetry). The results of the present investigation concur with the findings of the other 
studies (Gros et al, 2002; Sugiyama et al, 2001; Carlson and Wyss, 2000) indicating that 
C57 mice are modestly salt sensitivity. 
At least one other study used C57 mice as a model of salt sensitivity (Lantelme et 
al, 2002). However, in the study by Lantelme et al (2002), salt sensitivity was not 
actually measured. The major problem with assuming that C57 mice are salt sensitive 
and using them as a comparison group against salt resistant mice is the risk of finding 
negative results simply because the overall salt effect on the MAP of C57 mice is modest. 
Another study has suggested that C57 mice are salt resistant (Ni et al, 2003). Ni 
et al (2003) fed mice (n=8) a high salt diet (8% NaCl) for 7-10 days before measuring 
their MAP for 30 minutes using catheters. The mice, 7-8 weeks of age, showed an 
increase in MAP of about 11 mmHg which was reported as statistically insignificant. In 
118 
our present study, the total elevation of MAP was only 6 mmHg but this modest change 
was statistically significant. It has been reported by Van Vliet et al (2003) that the 
calculation of mean BP over extended periods of time (e.g. 12 or 24 hours) allows for less 
variation in reported values, smaller confidence limits and therefore an increased 
likelihood of detecting significant differences where they exist. Alternatively, extended 
sampling periods can allow smaller sample sizes to be used to test a hypothesis while 
maintaining adequate statistical resolution. Thus, the study by Ni et al (2003) may 
represent an example of the impact of the method of BP measurement on the overall 
results 
Based on the data from our study, it can be suggested that telemetry allows for 
detailed characterization of BP in mice. Telemetry allows for the continuous 
measurement of hemodynamic and activity data in a free moving and relatively stress 
free animal. It is the recommended technique for accurate assessment of BP in 
experimental animals (Kurtz et al, 2005). If measurement techniques other than 
telemetry are to be employed, the timing of the measurements may be vital to the results. 
According to the present data, the most likely time period to observe the initial salt-
induced elevations in MAP is within the first 5 days of exposure while long term notable 
increases in MAP may require 5-6 weeks of salt exposure to manifest. 
In addition to the 24h MAP, the MAP during the light and dark periods of the day 
were also independently examined. Monitoring of the MAP during the light period 
indicated a biphasic response with statistically significant changes in the response seen at 
the start of week 1 and during week 6. In the dark period the increase in MAP was more 
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sustained with statistical significance occurring during week 1, 3, 4 and 6. The more 
consistently significant effect of salt in the dark period may be due to the nocturnal 
lifestyle of the mice. C57 mice are more active during dark periods and less active 
during light periods (Van Vliet et al, 2003). Van Vliet et al (2003) have suggested that 
activity has a pronounced effect on the MAP with higher MAP values being observed in 
the active periods than in the inactive periods. Other studies also suggest that mice are 
nocturnal animals with higher average MAP values in the dark phase of the day when the 
animals are presumably more active, have high metabolic needs and are consuming more 
feed (Mattson, 2001; Carlson & Wyss, 2000; Menton et al, 2000; Li et al, 1999). By 
extension, if mice are more active and consume more salt during the dark phase, this 
could in part explain the greater effect of the high salt diet on the dark period MAP. 
Activity levels in the C57 mice also showed a tendency to be affected by the high 
salt diet. In the C57-HS mice, there was a tendency for an initial transient increase in the 
active time and the intensity of activity. This increase in activity may have reflected the 
mice searching for a more desirable food source than the newly started high salt diet. 
These initial increases in activity may have contributed to the initial BP response to salt. 
By increasing the time spent active, the mice would increase the time spent at the higher 
levels of MAP that are associated with activity, thus raising the overall 24h MAP. 
4.2 Basal BP in eNOS knockout Mice 
eNOS-KO mice had significantly greater basal MAP values than C57 mice. This 
was true for the dark and light periods as well as the 24h daily MAP values. 
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Furthermore, the eNOS-KO mice had significantly higher values for the daily range, 
minimum and maximum MAP which help explain why the basal BP was higher in 
eNOS-KO mice. These findings confirm previous studies showing that eNOS knockout 
mice have highe~ basal MAP values than C57 mice (Van Vliet et al, 2003). 
As stated earlier, eNOS provides an important contribution to endothelial 
mediated vasodilation, blood vessel tone, systemic and renal hemodynamics, and NaCl 
re-absorption in the renal tubules (Kone, 2004; Ortiz et al, 2003; Torreilles, 2001; Braam 
et al., 2000). Knocking out the eNOS gene will likely impair each of these functions. 
Consequently, eNOS knockout mice are expected to have increased vascular tone and 
reduced renal excretory capacity. Together, these may augment ECFV, peripheral 
resistance and BP. 
The elevated nature of the basal MAP in eNOS-KO mice in comparison to C57 
mice has previously been shown in several studies (Labonte & D'Orleans-Juste, 2004; 
Van Vliet, 2003; Beierwaltes et al, 2002). The only other study to date that has examined 
basal hemodynamics in eNOS knockout mice using telemetry data was conducted by Van 
Vliet et al (2003). In the latter study, an increase in 24h MAP, daily range, maximum 
and minimum MAP and 24h pulse pressure were demonstrated (Van Vliet, 2003). In 
contrast to the data presented by Van Vliet et al (2003), the evidence from the present 
study did not show significant differences in 24h pulse pressure. 
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4.3 Salt Sensitivity in eNOS knockout Mice 
eNOS-KO mice exhibited a significant rise in MAP when consuming a high salt 
diet. The 24h MAP of the eNOS-KO-HS mice was significantly increased throughout the 
experimental period and did not exhibit the decrease in MAP back to near normal values 
during the second week of the high salt diet as was observed in the C57 mice. Instead, 
the eNOS-KO-HS mice showed a sustained increase in MAP once the high salt diet was 
initiated. Overall, the two phases of salt sensitivity observed in the C57 control mice 
were not as evident in the eNOS-KO mice. It appeared that the mechanisms (i.e. ability 
of the C57 mice to effectively deal with salt induced volume loading) responsible for 
reversing the initial spike in MAP at about week 2 of high salt were not effective in the 
knockout strain. 
Although both the C57 and eNOS-KO mice exhibited statistically significant 
increases in MAP with consumption of a high salt diet, the response of eNOS-KO mice 
was about 2-2.5 times greater than that of C57 mice. The augmented response of the 
eNOS-KO mice suggests that NO may normally play an important role in the control of 
BP and salt balance. The removal of the eNOS gene could affect the MAP and salt 
sensitivity by altering several mechanisms including blood vessel tone, endothelial 
mediated vasodilation, systemic and intra-renal hemodynamics, and NaCl re-absorption 
within the renal tubules and collecting ducts (Kone, 2004; Ortiz et al, 2003; Torreilles, 
2001; Braam et al., 2000). 
The MAP during both the light and dark periods of the day were independently 
examined in the eNOS-KO mice. Although a tendency for the MAP to increase was seen 
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in the light phase, the effect of salt on the MAP in the eNOS-KO mice was mainly 
confined to the dark phase. Overall, in both the C57 and eNOS-KO mice, the MAP 
response to high salt appeared most pronounced during the dark phase of the day. As 
mentioned earli~r, the nocturnal lifestyle of the mice, as well as the increased activity and 
food intake during the dark phase of the day may explain the increases in MAP seen in 
the dark period. 
The eNOS-KO mice also exhibited an increase in the range and daily minimum 
and maximum MAP values. At the onset of the high salt diet there was a tendency for 
the range and maximum MAP values to increase and by the end of the experimental 
period all three variables were significantly elevated above control levels. In contrast, the 
daily range, maximum and minimum MAP in the C57 mice showed a tendency to 
increase but not reach statistical significance. Because the daily maximum increased 
more than the daily minimum in both the C57 and eNOS-KO mice, there was a resultant 
increase in the daily range of the MAP. The increase in the daily maximum MAP may 
have reflected an increase~ reactivity or variability ofBP in response to the high salt diet. 
4.4 The Contribution of Activity to Changes in MAP 
The activity levels of the C57 and eNOS-KO mice were both elevated by the high 
salt diet. The change in active time in response to a high dietary salt intake was most 
pronounced during the dark phase of the day. The increase in active time was more 
sustained in the eNOS-KO mice than in the C57 mice during the dark phase. In contrast 
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to the C57 mice, no significant differences were observed in the effect of high salt on the 
intensity of activity in the eNOS-KO mice. By spending a greater proportion of time 
active, the overall 24h MAP would be expected to increase because more time would be 
spent at the higher MAP level (rather than at the lower MAP levels associated with 
inactivity). Thus, at least part of the increase in MAP was due to the increases in the 
proportion of time spent active. However, as discussed below, much of the increase in 
MAP appears to have been independent of activity. 
The MAP levels associated with periods of activity and inactivity are important 
components that affect the overall 24h MAP. "MAP ACTIVE" refers to the average mean 
arterial pressure of the animal during periods of locomotor activity (activity signal> 0). 
The "MAPINACTIVE" refers to the average mean arterial pressure when the animal is 
inactive (activity signal= 0). Through out the day, the mice frequently alternate between 
periods of activity and inactivity with greater periods of activity and higher average MAP 
values being observed during the dark phase of the day. Both strains of mice exhibited 
an increase in MAP ACTIVE following both short (wk 1) and long (wk 5) term exposure to 
the high salt diet. As well, the MAPINACTIVE (basal) of the eNOS-KO mice was 
augmented by exposure to salt with greater effects seen during the latter phase of the 
experiment. 
The eNOS-KO mice showed a significant increase of the MAP ACTIVE in the 24h, 
light and dark periods, whereas the C57 mice only exhibited significance differences in 
the 24h . and light periods with a tendency seen in the dark phase. The elevation of the 
MAP ACTIVE suggests that not all the MAP increases observed with the high salt diet can 
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be explained by an increase in the amount of time spent active. The increase in 
MAP ACTIVE is independent of an increase in active time because for the MAP ACTIVE to 
increase the actual MAP when the animal is active has to be augmented. That is, an 
increase in MAP ACTIVE will increase the overall 24h MAP, independent of the increases 
in active time. 
Both the C57 and eNOS-KO mice increased their active time and MAP ACTIVE 
once the high salt diet was initiated, suggesting that these occurrences contribute to the 
initial increase in 24h MAP seen in the early phase of exposure to salt. As the 
experiment progressed, MAP remained elevated even though active time returned to near 
normal values. Thus, the increase in MAP was independent of any change in activity. In 
the C57 mice, the initial salt induced increases seen in MAP may be related to both the 
initial increases in activity and also the increase in MAP ACTIVE seen when the animals 
were exposed to a high salt diet. The latter elevation of the C57-HS mice MAP is likely 
due to the change in the MAP ACTIVE· The increased activity as well as the elevated 
MAP ACTIVE in the eNOS knockout mice may account for the initial increase seen in MAP 
within the first week of salt exposure. By week 5 of dietary salt exposure, increases are 
exhibited in both MAP ACTIVE and MAP INACTIVE suggesting that the animals were 
hypertensive irrespective of activity. 
To conclude, it appears that the initial salt-induced increases in MAP are a result 
of the augmented active time in combination with increases in the average MAP level 
during periods of activity and inactivity. By the end of the experiment, the active time 
and intensity of activity had returned to near normal levels, suggesting that the final 
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increase in 24h MAP must be largely independent of the time spent active. C57 mice 
showed less of an increase in MAP when exposed to salt. This may explain why they 
also showed less elevation in both MAP ACTIVE and MAP INACTIVE throughout the 
experiment. In .eNOS-KO mice, the salt-induced increases in the 24h MAP were more 
affected by variables other than activity (e.g. cardiovascular consequences of eliminating 
eNOS), giving further support to the important role eNOS plays in controlling the MAP 
when salt is high in the diet. 
4.5 Role of eNOS in Salt Sensitivity 
Salt sensitive hypertension has, in several studies, been shown to be affected by 
the presence or absence of NO. A rise in NO production normally occurs in response to 
an increase in dietary salt intake in normal rats whereas the increase in NO production 
with high salt appears to be attenuated in salt sensitivity hypertension (Kiraku et al, 
1999). Manning et al (2001) demonstrated that Dahl salt sensitive rats had a lower 
production of NO than their salt resistant counterparts. Furthermore, inhibition of NO 
production leads to salt sensitive hypertension. Several studies have shown that the 
administration of a NOS inhibitor to rats results in salt sensitivity (Tan et al, 2000; Rudd 
et al, 1999; Yamada et al, 1996; Tolins & Shultz, 1994). A final piece of evidence to 
support the importance of NO in salt sensitive hypertension in that increases in NO 
production can lead to the correction of salt sensitivity (Manning et al, 2001; Miyata & 
Cowley, 1999). In Dahl salt-sensitive rats, the administration of L-arginine can restore 
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the amount of NO excreted/produced to the level seen in salt-resistant rats eliminating the 
effect of salt on the MAP in the salt sensitive animals (Manning et al, 2001). 
In the present study, removal of the ability of NO to be produced by eNOS caused 
salt sensitive increases in BP to develop with a greater intensity than seen in control C57 
mice. While other investigators have examined the role of nNOS and iN OS, the role of 
eNOS has remained relatively unclear because selective . eNOS inhibitors are not 
available. By using eNOS-KO mice to examine salt sensitive hypertension we were able 
to look closely at the influence of this NOS isoform on MAP and salt sensitivity. 
As discussed above, eNOS-KO mice demonstrated a higher basal MAP level in 
the control period. This signifies the importance of NO produced from eNOS on the 
normal control ofBP. Once the high salt diet was initiated, the eNOS-KO mice exhibited 
a further increase in MAP that was 2-fold greater than the C57 mice. This affords 
evidence to the importance of eNOS in providing a normal response to a high salt diet. 
Both eNOS-KO mice as well as rats treated with L-NAME experience an increase in 
MAP when exposed to a high salt diet (Tan et al, 2000; Rudd et al, 1999; Yamada et al, 
1996; Tolins & Shultz, 1994). Since an increase in MAP was observed in the absence of 
eNOS as well as when all isoforms of NOS were inhibited, this suggests that NO 
produced from eNOS is at least partially responsible for the control of BP and salt 
balance. 
Recent studies have demonstrated that eNOS gene polymorphisms (variations in 
the alleles of the gene) are present in a number of people with hypertension and other 
cardiovascular diseases (Wattanapitayakul et al, 2001; Hingorani, 2000). My results 
127 
suggest that the presence of an eNOS gene polymorphism associated with reduced eNOS 
function may in fact increase the susceptibility of these individuals to salt sensitive 
hypertension. 
4.6 The "Renal Function Curve" in C57 and eNOS knockout Mice 
Historically, the relationship between salt intake/output and the MAP has been 
graphically depicted as the 'Renal Function Curve' (Norman et al, 1980). This curve 
represents the steady state balance between salt intake/output and MAP. Because it 
represents the steady state, it reflects the influence of every physiological mechanism in 
the body that effects salt excretion and MAP, not just the influence of the kidney. 
Using data from the present study, renal function curves were created to provide a 
graphical summary of the basal MAP and the BP response to salt in both the C57 and 
eNOS-KO mice (figure 35). Salt intakes for the renal function curve were estimated in 
terms of the number of mEqlkg body weight/day consumed during the control period and 
during the first week of the experimental diet. These intakes were then plotted against 
the MAP level at the end of the control period and first week of experimental diet. The 
points on the graph represent the MAP at a given level of sodium intake under steady 
state conditions (i.e. after 1 week on a given level of salt intake). The increased basal 
MAP of the eNOS-KO mice on the regular salt diet is apparent as the rightward shift of 
the curve (point C in comparison to point A). As has been described by Van Vliet and 
Montani (2005), a rightward shift of the renal function curve will result in a higher 
equilibrium BP level and hypertension. Once the sodium content of the diet was 
128 
"Renal Function Curve" 
300 Control Period Vs. Salt Week 1 
250 D 
eNOS-KO-HS 
-
So/o NaCI Diet 
>. 200 ro 8 Cl) ""'0 
~ 
-ns 3: C57-HS 
.., 
..0 8% NaCI Diet 
c 0') 150 
·-
+ ~ 
-ns 0"' z w 100 E 
-
50 C57-HS eNOS-KO-HS 
A Control Diet c Control Diet 
0 
100 110 120 130 140 
24h MAP(mmHg) 
Figure 35: Renal function curve of C57 and eNOS knockout mice. The lines on the 
graph represent the MAP at a given sodium intake level. The near vertical line in the 
case of the C57 mice indicates a modest salt sensitivity whereas the shallow slope of the 
eNOS-KO group represents an enhanced effect of salt on the MAP. The rightward shift 
of the renal function curve of the eNOS-KO mice represents an elevated basal MAP 
when compared to C57 mice. 
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increased, the MAP of the eNOS-KO mice increased along the slope of the renal function 
curve from point C to point D. The renal function curve of the eNOS-KO mice has a 
slope of 20.7 ± 7.9 which is significantly different than the slope of the renal function 
curve of the C57 mice (49.5 ± 5.2). The relatively steep line in the case of the C57 mice 
indicates a modest level of salt sensitivity, as a vertical renal function curve indicates 
complete salt insensitivity (Van Vliet & Montani, 2005). In contrast, the eNOS-KO mice 
have a renal function curve with a shallower slope, indicative of their greater salt 
sensitivity. In summary, eNOS-KO mice have an elevated basal MAP as is evident by 
the rightward shift of their renal function curve and an increased BP response to salt 
which is seen in the shallow slope of their renal function curve. 
Although it has now been shown that eNOS-KO mice are salt sensitive and it can 
be assumed that it is the absence of the eNOS gene that accounts for the augmented MAP 
response to the high salt diet, the exact mechanisms that cause this increase to occur are 
unknown. It can be speculated that one or more of the many physiological systems 
affected by eNOS could play a role in the elevated basal MAP and the augmented salt 
sensitivity. For example, increases in MAP could be due to an effect on blood vessel 
tone and or reactivity, renin secretion or tubular re-absorption (Ortiz et al, 2003; Parzak et 
al, 2001). 
4. 7 Conclusion 
eNOS-KO mice exhibited an augmented basal MAP and also a heightened level 
of salt sensitivity compared to the control C57 mice. The short term increase in the 
130 
proportion of time spent active likely contributed to the initial rise in MAP observed once 
the high salt diet was initiated. The long term increase in the MAP appeared to be highly 
independent of the amount of time spent active. 
Previous. studies have shown that NO plays a role in the body's normal response 
to salt and impairment of this action is a factor in salt sensitivity. These studies have 
shown that the MAP increased in the presence of a high salt diet when a non selective 
NOS inhibitor was administered. Studies on eNOS gene polymorphisms also suggest 
that the presence of an irregular eNOS gene increases the occurrence or risk of 
hypertension and cardiovascular disease (Wattanapitayakul et al, 2001; Hingorani, 2000), 
though an effect on salt sensitivity has not been investigated. Our study demonstrated 
that the selective removal of eNOS caused an increase in basal MAP and salt sensitivity. 
Our results suggest that eNOS may play an important role in salt sensitive hypertension. 
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